SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0    0 Behavioral pharmacology research has made important contributions to the conceptualization of addictions and to the treatment and prevention of substance abuse .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0    0 Behavioral_JJ_NN1_NP1 pharmacology_NN1 research_NN1 has_VHZ made_VVN important_JJ contributions_NN2 to_II the_AT conceptualization_NN1 of_IO addictions_NN2 and_CC to_II the_AT treatment_NN1 and_CC prevention_NN1 of_IO substance_NN1 abuse_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0    1 It has its intellectual roots in the experimental analysis of behavior and close ties with experimental and clinical pharmacology .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0    1 It_PPH1 has_VHZ its_Z' intellectual_JJ_NN1 roots_NN2 in_II the_AT experimental_JJ analysis_NN1 of_IO behavior_NN1 and_CC close_JJ_VV0 ties_NN2 with_IW experimental_JJ and_CC clinical_JJ pharmacology_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0    2 Because substance abusers self administer drugs repeatedly , this presents the opportunity for learning to occur .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0    2 Because_CS substance_NN1 abusers_NN2 self_NN1 administer_VV0 drugs_NN2 repeatedly_RR ,_Y this_DD1 presents_VVZ the_AT opportunity_NN1 for_IF learning_VVG_NN1 to_TO occur_VVI ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0    3 The application of learning theory to the laboratory study of drug effects in both animals and humans has been a major contribution of behavioral pharmacology research .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0    3 The_AT application_NN1 of_IO learning_NN1 theory_NN1 to_II the_AT laboratory_NN1 study_NN1 of_IO drug_NN1 effects_NN2 in_II_RP@ both_RR animals_NN2 and_CC humans_NN2 has_VHZ been_VBN a_AT1 major_JJ contribution_NN1 of_IO behavioral_JJ_NN1 pharmacology_NN1 research_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0    4 Principles derived from over 40 years of behavioral pharmacology research are now widely accepted in the addiction field and have contributed to the development of both pharmacological and behavioral treatments .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0    4 Principles_NN2 derived_VVN from_II over_RG 40_MC years_NNT2 of_IO behavioral_JJ_NN1 pharmacology_NN1 research_NN1 are_VBR now_RT widely_RR accepted_VVN_VVD in_II the_AT addiction_NN1 field_NN1 and_CC have_VH0 contributed_VVN to_II the_AT development_NN1 of_IO both_DB2_RR pharmacological_JJ and_CC behavioral_JJ_NN1 treatments_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0    5 Drug abuse prevention through the assessment of the abuse liability of new medications has also been an important applied area of research in the field .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0    5 Drug_NN1 abuse_NN1 prevention_NN1 through_II the_AT assessment_NN1 of_IO the_AT abuse_NN1 liability_NN1 of_IO new_JJ medications_NN2 has_VHZ also_RR been_VBN an_AT1 important_JJ applied_JJ area_NN1 of_IO research_NN1 in_II the_AT field_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0    6 Personal reflections of three behavioral pharmacologists provide examples of important influences in the field .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0    6 Personal_JJ reflections_NN2 of_IO three_MC behavioral_JJ pharmacologists_NN2 provide_VV0 examples_NN2 of_IO important_JJ influences_NN2 in_II the_AT field_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0    7 <p> Behavioral pharmacology research grew from roots in experimental psychology and the experimental analysis of behavior to address drug effects on behavior and how the contexts in which drugs are historical overview of contributions of both animal and human behavioral pharmacology research to the study of drug abuse .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0    7 <p>_Y Behavioral_JJ_NN1 pharmacology_NN1 research_NN1 grew_VVD from_II roots_NN2 in_II experimental_JJ psychology_NN1 and_CC the_AT experimental_JJ analysis_NN1 of_IO behavior_NN1 to_TO address_VVI drug_NN1 effects_NN2 on_II behavior_NN1 and_CC how_RRQ the_AT contexts_NN2 in_II which_DDQ drugs_NN2 are_VBR historical_JJ overview_NN1 of_IO contributions_NN2 of_IO both_RR animal_NN1_JJ% and_CC human_JJ behavioral_JJ_NN1 pharmacology_NN1 research_NN1 to_II the_AT study_NN1 of_IO drug_NN1 abuse_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0    8 Behavioral pharmacologists developed important laboratory animal models for the learned aspects of drug abuse that subsequently led to close counterparts in human research .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0    8 Behavioral_JJ_NN1 pharmacologists_NN2 developed_VVD_VVN important_JJ laboratory_NN1 animal_NN1 models_NN2 for_IF the_AT learned_JJ@ aspects_NN2 of_IO drug_NN1 abuse_NN1_VV0@ that_CST subsequently_RR led_VVN_VVD to_TO close_VVI counterparts_NN2 in_II human_JJ_NN1 research_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0    9 Some of the most important models use studies of the stimulus properties of drugs where they function as conditioned or unconditioned stimuli in classical conditioning and discriminative or reinforcing stimuli in operant learning .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0    9 Some_DD of_IO the_AT most_RGT important_JJ models_NN2 use_VV0 studies_NN2 of_IO the_AT stimulus_NN1 properties_NN2 of_IO drugs_NN2 where_CS_RRQ they_PPHS2 function_VV0@ as_CSA_RG@ conditioned_VVN_JJ or_CC unconditioned_JJ stimuli_NN2 in_II classical_JJ conditioning_NN1_JJ and_CC discriminative_JJ or_CC reinforcing_VVG_JJ@ stimuli_NN2 in_II operant_JJ_NN1 learning_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   10 Important applications of behavioral pharmacology research have helped form learning theories of addiction , assess the abuse potential of medications , and develop both pharmacological and behavioral treatments for addiction .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   10 Important_JJ applications_NN2 of_IO behavioral_JJ_NN1 pharmacology_NN1 research_NN1 have_VH0 helped_VVN form_NN1_VV0 learning_NN1_VVG theories_NN2 of_IO addiction_NN1 ,_Y assess_VV0 the_AT abuse_NN1 potential_NN1 of_IO medications_NN2 ,_Y and_CC develop_VV0 both_RR pharmacological_JJ and_CC behavioral_JJ_NN1 treatments_NN2 for_IF addiction_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   11 <p> L : ANIMAL BEHAVIORAL PHARMACOLOGY Behavioral pharmacology research grew from the interdisciplinary work of pharmacologists and behavioral scientists .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   11 <p>_Y L_ZZ1_NP1@ :_Y ANIMAL_NN1 BEHAVIORAL_NP1_NN1_JJ PHARMACOLOGY_NP1_NN1 Behavioral_NP1_JJ_NN1 pharmacology_NN1 research_NN1 grew_VVD from_II the_AT interdisciplinary_JJ work_NN1 of_IO pharmacologists_NN2 and_CC behavioral_JJ_NN1 scientists_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   12 One domain of behavioral sciences particularly well-represented among early researchers was the experimental analysis of behavior as articulated by Skinner ( 1938 ) , a field of research that utilized scientific methods described by Sidman ( 1960 ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   12 One_MC1 domain_NN1 of_IO behavioral_JJ_NN1 sciences_NN2 particularly_RR well-represented_JJ_NN1 among_II early_JJ researchers_NN2 was_VBDZ the_AT experimental_JJ analysis_NN1 of_IO behavior_NN1 as_CSA articulated_VVN by_II Skinner_NP1 (_Y 1938_MC )_Y ,_Y a_AT1 field_NN1 of_IO research_NN1 that_CST utilized_VVD scientific_JJ methods_NN2 described_VVN by_II Sidman_NP1_NN1 (_Y 1960_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   13 An important early focus of the work , exemplified by the work of Dews and others , was on the interactions of drugs with Kelleher , 1970 ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   13 An_AT1 important_JJ early_JJ focus_NN1 of_IO the_AT work_NN1 ,_Y exemplified_VVN by_II the_AT work_NN1 of_IO Dews_NN2 and_CC others_NN2 ,_Y was_VBDZ on_II the_AT interactions_NN2 of_IO drugs_NN2 with_IW Kelleher_NP1 ,_Y 1970_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   14 In well-controlled laboratory studies in animals , it was shown that the specific effect that a drug produced on behavior depended , to a large extent , on the behavioral history of the animal !
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   14 In_II well-controlled_JJ_NN1 laboratory_NN1 studies_NN2 in_II animals_NN2 ,_Y it_PPH1 was_VBDZ shown_VVN that_CST the_AT specific_JJ effect_NN1 that_CST a_AT1 drug_NN1 produced_VVN_VVD on_II behavior_NN1 depended_VVD_VVN ,_Y to_II a_AT1 large_JJ extent_NN1 ,_Y on_II the_AT behavioral_JJ_NN1 history_NN1 of_IO the_AT animal_NN1 !_Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   15 and on what the animal had been trained to do when the drug was administered .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   15 and_CC on_II what_DDQ the_AT animal_NN1 had_VHD been_VBN trained_VVN to_TO do_VDI when_CS the_AT drug_NN1 was_VBDZ administered_VVN ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   16 Depending on the specified schedule of reinforcement , amphetamine could either stimulate or suppress behavior .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   16 Depending_II21 on_II22 the_AT specified_JJ@ schedule_NN1 of_IO reinforcement_NN1 ,_Y amphetamine_NN1_VV0 could_VM either_RR stimulate_VVI or_CC suppress_VVI behavior_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   17 The observation in the animal laboratory that drug effects were not the immutable result of their pharmacological properties but could differ from animal to animal , from time to time , and from circumstance to circumstance , was consistent with the observation of similar response variability in humans .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   17 The_AT observation_NN1 in_II the_AT animal_NN1 laboratory_NN1 that_CST_DD1 drug_NN1 effects_NN2 were_VBDR not_XX the_AT immutable_JJ result_NN1 of_IO their_APPGE pharmacological_JJ properties_NN2 but_CCB could_VM differ_VVI from_II animal_NN1 to_II animal_NN1 ,_Y from_RR41 time_RR42 to_RR43 time_RR44 ,_Y and_CC from_II circumstance_NN1 to_II circumstance_NN1 ,_Y was_VBDZ consistent_JJ with_IW the_AT observation_NN1 of_IO similar_JJ response_NN1 variability_NN1 in_II humans_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   18 Previously , individual differences in addictive behavior evident in the general population were attributed to moral weakness or personality defects in substance abusers or perhaps to genetically inherited flaws .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   18 Previously_RR ,_Y individual_JJ differences_NN2 in_II addictive_JJ behavior_NN1 evident_JJ in_II the_AT general_JJ_NN1 population_NN1 were_VBDR attributed_VVN to_II moral_JJ weakness_NN1 or_CC personality_NN1 defects_NN2 in_II substance_NN1 abusers_NN2 or_CC perhaps_RR to_II_TO genetically_RR inherited_VVN_VVD_JJ@ flaws_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   19 Whatever the basis , substance abuse and addiction were seen as problems of a flawed minority .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   19 Whatever_DDQV the_AT basis_NN1 ,_Y substance_NN1 abuse_NN1 and_CC addiction_NN1 were_VBDR seen_VVN as_CSA_II@ problems_NN2 of_IO a_AT1 flawed_JJ minority_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   20 Behavioral pharmacology offered a perspective from which to study the way drugs of abuse produced their behavioral and addictive effects that could account animal behavioral pharmacologists studied classes of drugs beyond those with abuse potential ( Pickens , 1977 ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   20 Behavioral_JJ_NN1 pharmacology_NN1 offered_VVD_VVN a_AT1 perspective_NN1 from_II which_DDQ to_TO study_VVI the_AT way_NN1 drugs_NN2 of_IO abuse_NN1 produced_VVD_VVN their_APPGE behavioral_NN1_JJ and_CC addictive_JJ effects_NN2 that_CST_DD1 could_VM account_VVI animal_NN1_JJ% behavioral_NN1_JJ pharmacologists_NN2 studied_VVD_VVN classes_NN2 of_IO drugs_NN2 beyond_II those_DD2 with_IW abuse_NN1 potential_NN1 (_Y Pickens_NP1 ,_Y 1977_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   21 Behavioral pharmacology evolved in parallel with the development of many new types of psychotherapeutic medication 's ( e.g. , antipsychotics , antidepressants , and anxiolytics ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   21 Behavioral_JJ_NN1 pharmacology_NN1 evolved_VVN_VVD in_II_RP@ parallel_NN1_JJ_RR with_IW the_AT development_NN1 of_IO many_DA2 new_JJ types_NN2 of_IO psychotherapeutic_JJ medication_NN1 's_GE (_Y e.g._REX ,_Y antipsychotics_NN2_NN1 ,_Y antidepressants_NN2 ,_Y and_CC anxiolytics_NN2_NN1 )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   22 Indeed , behavioral pharmacologists were active in developing animal test procedures to model and predict desired clinical responses to these medications .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   22 Indeed_RR ,_Y behavioral_JJ_NN1 pharmacologists_NN2 were_VBDR active_JJ in_II developing_JJ_VVG animal_NN1 test_NN1_VV0 procedures_NN2 to_TO model_VVI and_CC predict_VVI desired_JJ@_VVN clinical_JJ responses_NN2 to_II these_DD2 medications_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   23 For example , drugs with anti-anxiety effects were often shown to increase rates of lever-pressing behavior of rats or keypecking behavior of pigeons that were decreased by punishment ( Barrett , 2002 ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   23 For_REX21 example_REX22 ,_Y drugs_NN2 with_IW anti-anxiety_JJ effects_NN2 were_VBDR often_RR shown_VVN to_TO increase_VVI rates_NN2 of_IO lever-pressing_JJ_NN1 behavior_NN1 of_IO rats_NN2 or_CC keypecking_VVG_JJ@ behavior_NN1 of_IO pigeons_NN2 that_CST were_VBDR decreased_VVN by_II punishment_NN1 (_Y Barrett_NP1 ,_Y 2002_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   24 The disinhibition of behavior suppressed by punishment has become a standard behavioral assay for the anti-anxiety activity of drugs .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   24 The_AT disinhibition_NN1 of_IO behavior_NN1 suppressed_VVN by_II punishment_NN1 has_VHZ become_VVN@ a_AT1 standard_JJ behavioral_JJ_NN1 assay_NN1 for_IF the_AT anti-anxiety_JJ_NN1 activity_NN1 of_IO drugs_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   25 Similarly , conditioned shock avoidance responding was employed as an assay for antipsychotic medications used to treat schizophrenia .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   25 Similarly_RR ,_Y conditioned_JJ shock_NN1 avoidance_NN1 responding_VVG was_VBDZ employed_VVN as_II an_AT1 assay_NN1 for_IF antipsychotic_JJ medications_NN2 used_VMK to_TO treat_VVI schizophrenia_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   26 This historical association of behavioral pharmacology with psychotherapeutic medication development has been well described ( McKim , 2007 ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   26 This_DD1 historical_JJ association_NN1 of_IO behavioral_JJ_NN1 pharmacology_NN1 with_IW psychotherapeutic_JJ medication_NN1 development_NN1 has_VHZ been_VBN well_RR described_VVN (_Y McKim_NP1 ,_Y 2007_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   27 <p> Thompson and Schuster 's textbook ( 1968 ) offered the first comprehensive explanation of the application of behavioral pharmacology to the study of drug abuse .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   27 <p>_Y Thompson_NP1 and_CC Schuster_NP1_NN1 's_GE textbook_NN1 (_Y 1968_MC )_Y offered_VVD the_AT first_MD comprehensive_JJ explanation_NN1 of_IO the_AT application_NN1 of_IO behavioral_JJ_NN1 pharmacology_NN1 to_II the_AT study_NN1 of_IO drug_NN1 abuse_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   28 The appearance of this stimulus properties of drugs ( Pickens Thompson , 1970 ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   28 The_AT appearance_NN1 of_IO this_DD1 stimulus_NN1 properties_NN2 of_IO drugs_NN2 (_Y Pickens_NP1 Thompson_NP1 ,_Y 1970_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   29 A powerful theory that guided much of this research is that drugs could perform the same stimulus functions in stimulus-response learning as external environmental stimuli .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   29 A_AT1_ZZ1 powerful_JJ theory_NN1 that_CST guided_VVD much_DA1 of_IO this_DD1 research_NN1 is_VBZ that_CST drugs_NN2 could_VM perform_VVI the_AT same_DA stimulus_NN1 functions_NN2_VVZ@ in_II stimulus-response_JJ_NN1 learning_NN1 as_CSA external_JJ environmental_JJ stimuli_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   30 An important early influence on this theory was the work of Wikler ( 1973 ) on the ability of environments in which drug abusers lived to trigger drug craving , withdrawal symptoms , and relapse .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   30 An_AT1 important_JJ early_JJ_RR influence_NN1_VV0 on_II this_DD1 theory_NN1 was_VBDZ the_AT work_NN1 of_IO Wikler_NP1_NN1 (_Y 1973_MC )_Y on_II the_AT ability_NN1 of_IO environments_NN2 in_II which_DDQ drug_NN1_VV0% abusers_NN2 lived_VVD_VVN to_TO trigger_VVI drug_NN1 craving_VVG_NN1@ ,_Y withdrawal_NN1 symptoms_NN2 ,_Y and_CC relapse_NN1_VV0 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   31 Wikler explained this as a form of classical conditioning where the external cues were the conditioned stimuli paired with drug-related unconditioned stimuli that came to elicit conditioned responses experienced as craving and relapse .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   31 Wikler_NP1@_NN1 explained_VVD this_DD1 as_II_CSA a_AT1 form_NN1 of_IO classical_JJ conditioning_NN1_JJ where_CS_RRQ the_AT external_JJ cues_NN2 were_VBDR the_AT conditioned_JJ stimuli_NN2 paired_VVN_VVD with_IW drug-related_JJ unconditioned_JJ stimuli_NN2 that_CST came_VVD to_TO elicit_VVI conditioned_JJ responses_NN2 experienced_VVN_VVD as_CSA_II@ craving_VVG_JJ@ and_CC relapse_NN1_VV0 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   32 The development of animal models for the classical conditioning of drug effects greatly expanded research in this area .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   32 The_AT development_NN1 of_IO animal_NN1 models_NN2 for_IF the_AT classical_JJ conditioning_NN1 of_IO drug_NN1 effects_NN2 greatly_RR expanded_JJ_VVN research_NN1 in_II this_DD1 area_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   33 <p> Another important advance stemming from the integration of these two sciences was the demonstration that drugs could function as reinforcing stimuli in operant conditioning procedures similar to other reinforcers , such as food .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   33 <p>_Y Another_DD1 important_JJ advance_NN1 stemming_VVG from_II the_AT integration_NN1 of_IO these_DD2 two_MC sciences_NN2 was_VBDZ the_AT demonstration_NN1 that_CST drugs_NN2 could_VM function_VVI as_RG@_CSA_II@ reinforcing_JJ@_VVG stimuli_NN2 in_II operant_JJ_NN1 conditioning_NN1 procedures_NN2 similar_JJ to_II other_JJ reinforcers_NN2 ,_Y such_II21 as_II22 food_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   34 Early studies by Thompson and Schuster ( 1964 ) and Deneau , Yanagita , and Seevers ( 1969 ) in monkeys and by Weeks ( 1962 ) in rats these studies , animals pressed response levers to obtain intravenous drug injections .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   34 Early_JJ_RR studies_NN2 by_II Thompson_NP1 and_CC Schuster_NP1_NN1 (_Y 1964_MC )_Y and_CC Deneau_NP1_NN1 ,_Y Yanagita_NP1 ,_Y and_CC Seevers_NP1 (_Y 1969_MC )_Y in_II monkeys_NN2 and_CC by_II Weeks_NP1@_NNT2 (_Y 1962_MC )_Y in_II rats_NN2 these_DD2 studies_NN2 ,_Y animals_NN2 pressed_VVD_VVN response_NN1 levers_NN2 to_TO obtain_VVI intravenous_JJ drug_NN1 injections_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   35 It was found that animals would self-administer most drugs abused by people .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   35 It_PPH1 was_VBDZ found_VVN that_CST animals_NN2 would_VM self-administer_VVI most_DAT drugs_NN2 abused_VVN by_II people_NN ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   36 Extensive cross-species and cross-drug commonalities have been noted in the relationships of pharmacological and environmental and behavioral factors to drug self-administration ( Griffiths , Bigelow , Henningfield , 1980 ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   36 Extensive_JJ cross-species_NN_JJ and_CC cross-drug_JJ_NN1 commonalities_NN2 have_VH0 been_VBN noted_VVN in_II the_AT relationships_NN2 of_IO pharmacological_JJ and_CC environmental_JJ and_CC behavioral_JJ_NN1 factors_NN2 to_II drug_NN1 self-administration_NN1 (_Y Griffiths_NP1 ,_Y Bigelow_NP1_VV0_NN1 ,_Y Henningfield_NP1 ,_Y 1980_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   37 Also , some substances regularly consumed by humans but not previously considered addictive or dependence producing ( e.g. , tobacco ) have now come to be seen and understood within this same framework .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   37 Also_RR ,_Y some_DD substances_NN2 regularly_RR consumed_VVN by_II humans_NN2 but_CCB not_XX previously_RR considered_VVN_VVD addictive_JJ or_CC dependence_NN1 producing_VVG (_Y e.g._REX ,_Y tobacco_NN1 )_Y have_VH0 now_RT come_VVN to_TO be_VBI seen_VVN and_CC understood_VVN_VVD within_II this_DD1 same_DA framework_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   38 The development of animal drug self-administration models is probably the single greatest scientific advance that freed us from the view of substance abuse risk and vulnerability being relevant only to a flawed minority of the population .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   38 The_AT development_NN1 of_IO animal_NN1 drug_NN1 self-administration_NN1_JJ models_NN2 is_VBZ probably_RR the_AT single_JJ greatest_JJT scientific_JJ advance_NN1 that_CST freed_VVD us_PPIO2 from_II the_AT view_NN1 of_IO substance_NN1 abuse_NN1 risk_NN1 and_CC vulnerability_NN1 being_VBG relevant_JJ only_RR to_II a_AT1 flawed_JJ minority_NN1 of_IO the_AT population_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   39 The development of these animal laboratory models was a great scientific advance that highlighted the biological normality of drug reinforcement and the universality , or near-universality , of vulnerability to drug reinforcement and drug abuse .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   39 The_AT development_NN1 of_IO these_DD2 animal_NN1_JJ% laboratory_NN1 models_NN2 was_VBDZ a_AT1 great_JJ scientific_JJ advance_NN1 that_CST highlighted_VVD the_AT biological_JJ normality_NN1 of_IO drug_NN1 reinforcement_NN1 and_CC the_AT universality_NN1 ,_Y or_CC near-universality_NN1_JJ ,_Y of_IO vulnerability_NN1 to_II drug_NN1 reinforcement_NN1 and_CC drug_NN1 abuse_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   40 <p> Application of learning principles to the study of pharmacology demonstrated that drugs could also function as discriminative stimuli ( Schuster Balster , 19,77 ) presented with two response levers ; only one will result in food reinforcement .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   40 <p>_Y Application_NN1 of_IO learning_VVG_NN1 principles_NN2 to_II the_AT study_NN1 of_IO pharmacology_NN1 demonstrated_VVD_VVN that_CST drugs_NN2 could_VM also_RR function_VVI as_RG@_CSA discriminative_JJ stimuli_NN2 (_Y Schuster_NP1 Balster_NP1_NN1 ,_Y 19,77_MC )_Y presented_VVN with_IW two_MC response_NN1 levers_NN2 ;_Y only_RR one_PN1_MC1 will_VM result_VVI in_II food_NN1 reinforcement_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   41 If the animals were trained that pressing the left lever is reinforced on days when they were injected with an active drug and pressing the right lever is reinforced on days when they were injected with placebo , they soon learned to detect whether they were given the active drug and demonstrated this by selecting the correct lever .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   41 If_CS the_AT animals_NN2 were_VBDR trained_VVN that_CST_DD1 pressing_VVG the_AT left_JJ lever_NN1 is_VBZ reinforced_VVN on_II days_NNT2 when_RRQ they_PPHS2 were_VBDR injected_VVN with_IW an_AT1 active_JJ drug_NN1 and_CC pressing_VVG the_AT right_JJ_NN1 lever_NN1 is_VBZ reinforced_VVN on_II days_NNT2 when_RRQ they_PPHS2 were_VBDR injected_VVN with_IW placebo_NN1 ,_Y they_PPHS2 soon_RR learned_VVN_VVD to_TO detect_VVI whether_CSW they_PPHS2 were_VBDR given_VVN the_AT active_JJ drug_NN1 and_CC demonstrated_VVN this_DD1 by_II selecting_VVG the_AT correct_JJ lever_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   42 This paradigm provides a mechanism to measure and characterize the interoceptive effects of drugs in nonverbal species .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   42 This_DD1 paradigm_NN1 provides_VVZ a_AT1 mechanism_NN1 to_TO measure_VVI and_CC characterize_VVI the_AT interoceptive_JJ effects_NN2 of_IO drugs_NN2 in_II nonverbal_JJ_NN1 species_NN ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   43 This technique has been effectively applied to the characterization and classification of novel entities according to their similarities and dissimilarities by comparing these discriminative stimulus effects to a standard drug with known effects .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   43 This_DD1 technique_NN1 has_VHZ been_VBN effectively_RR applied_VVN_VVD to_II the_AT characterization_NN1 and_CC classification_NN1 of_IO novel_JJ_NN1 entities_NN2 according_II21 to_II22 their_APPGE similarities_NN2 and_CC dissimilarities_NN2 by_II comparing_VVG these_DD2 discriminative_JJ stimulus_NN1 effects_NN2 to_II a_AT1 standard_JJ_NN1 drug_NN1 with_IW known_JJ@ effects_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   44 Drug discrimination methods have also been used to study the internal states related to withdrawal from drugs of abuse through training the discrimination of different physiologic states .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   44 Drug_NN1 discrimination_NN1 methods_NN2 have_VH0 also_RR been_VBN used_VVN to_TO study_VVI the_AT internal_JJ states_NN2 related_VVN_VVD to_II withdrawal_NN1 from_II drugs_NN2 of_IO abuse_NN1 through_II training_VVG@ the_AT discrimination_NN1 of_IO different_JJ physiologic_JJ states_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   45 <p> Tolerance , previously thought to be a purely pharmacological process , is now known to be in part a learning process ( Schuster , Dockens , Woods , 1966 ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   45 <p>_Y Tolerance_NN1 ,_Y previously_RR thought_VVN_VVD to_TO be_VBI a_AT1 purely_RR pharmacological_JJ process_NN1 ,_Y is_VBZ now_RT known_VVN to_TO be_VBI in_RR21 part_RR22 a_AT1 learning_NN1 process_NN1 (_Y Schuster_NP1_NN1 ,_Y Dockens_NP1_NN2 ,_Y Woods_NP1 ,_Y 1966_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   46 Dramatic differences in the extent depending on whether animals have an opportunity to practice the behavior during active drug exposure .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   46 Dramatic_JJ differences_NN2 in_II the_AT extent_NN1 depending_II21 on_II22 whether_CSW animals_NN2 have_VH0 an_AT1 opportunity_NN1 to_II practice_NN1 the_AT behavior_NN1 during_II active_JJ drug_NN1 exposure_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   47 Even analgesic tolerance has a strong learning component .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   47 Even_RR analgesic_JJ@_NN1 tolerance_NN1 has_VHZ a_AT1 strong_JJ learning_NN1 component_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   48 <p> Animal behavioral pharmacology research on the environmental determinants of drug action and on the stimulus properties of drugs provided the scientific basis for a learning theory of addiction ( Barrett , 2002 ; Thompson Schuster , 1968 ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   48 <p>_Y Animal_NN1 behavioral_NN1_JJ pharmacology_NN1 research_NN1 on_II the_AT environmental_JJ determinants_NN2 of_IO drug_NN1 action_NN1 and_CC on_II the_AT stimulus_NN1 properties_NN2 of_IO drugs_NN2 provided_VVD_CS_VVN the_AT scientific_JJ basis_NN1 for_IF a_AT1 learning_NN1 theory_NN1 of_IO addiction_NN1 (_Y Barrett_NP1 ,_Y 2002_MC ;_Y Thompson_NP1 Schuster_NP1 ,_Y 1968_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   49 This theory dominates contemporary conceptualizations of how people come to develop and sustain drug abuse and how the manifestations of the problem can differ from person to person , place to place , and time to time .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   49 This_DD1 theory_NN1 dominates_VVZ contemporary_JJ conceptualizations_NN2 of_IO how_RRQ people_NN come_VV0 to_TO develop_VVI and_CC sustain_VVI drug_NN1 abuse_NN1 and_CC how_RRQ the_AT manifestations_NN2 of_IO the_AT problem_NN1 can_VM differ_VVI from_II person_NN1 to_II person_NN1 ,_Y place_VV0 to_TO place_VVI ,_Y and_CC time_NNT1 to_II time_NNT1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   50 With these animal models , one could readily incorporate other scientific developments in both the behavioial ( e.g. behavioral economics , decision theory ) and pharmacological ( e.g. receptor theory , molecular biology ) sciences into these methodologies .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   50 With_IW these_DD2 animal_NN1_JJ% models_NN2 ,_Y one_PN1 could_VM readily_RR incorporate_VVI other_JJ scientific_JJ developments_NN2 in_II both_DB2 the_AT behavioial_JJ (_Y e.g._REX behavioral_JJ_NN1 economics_NN1 ,_Y decision_NN1 theory_NN1 )_Y and_CC pharmacological_JJ (_Y e.g._REX receptor_NN1 theory_NN1 ,_Y molecular_JJ biology_NN1 )_Y sciences_NN2 into_II these_DD2 methodologies_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   51 <p> L : HUMAN BEHAVIORAL PHARMACOLOGY A remarkable strength of these behavioral pharmacology models in laboratory animals was their seamless transition to human laboratory research .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   51 <p>_Y L_ZZ1_NP1@ :_Y HUMAN_JJ BEHAVIORAL_JJ_NN1_NP1 PHARMACOLOGY_NN1_NP1 A_ZZ1 remarkable_JJ strength_NN1 of_IO these_DD2 behavioral_JJ pharmacology_NN1 models_NN2 in_II laboratory_NN1 animals_NN2 was_VBDZ their_APPGE seamless_JJ transition_NN1 to_II human_JJ_NN1 laboratory_NN1 research_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   52 Indeed , many of the procedures used in human laboratory studies have almost direct counterparts in animal models .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   52 Indeed_RR ,_Y many_DA2 of_IO the_AT procedures_NN2 used_VVN_VVD in_II human_JJ_NN1 laboratory_NN1 studies_NN2 have_VH0 almost_RR direct_JJ counterparts_NN2 in_II animal_NN1 models_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   53 This is an compared with the animal to human translation problems that occur in other fields .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   53 This_DD1 is_VBZ an_AT1 compared_VVN with_IW the_AT animal_NN1 to_II human_JJ_NN1 translation_NN1 problems_NN2 that_CST occur_VV0 in_II_RP@ other_JJ fields_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   54 Perhaps the earliest study to adapt these behavioral methods to issues of substance abuse in humans examined the basic behavioral parameters of alcohol intake using oral self-administration in alcoholics ( Mello Mendelson , 1965 ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   54 Perhaps_RR the_AT earliest_JJT_RRT study_NN1_VV0@ to_TO adapt_VVI these_DD2 behavioral_JJ methods_NN2 to_II issues_NN2 of_IO substance_NN1 abuse_NN1 in_II humans_NN2 examined_VVD_VVN the_AT basic_JJ behavioral_JJ_NN1 parameters_NN2 of_IO alcohol_NN1 intake_NN1 using_VVG oral_JJ_NN1 self-administration_NN1 in_II alcoholics_NN2 (_Y Mello_NP1 Mendelson_NP1 ,_Y 1965_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   55 Self-administration procedures were subsequently applied to the study of illicit drugs , such as heroin ( e.g. , Mello Mendelson , 1978 ) and cocaine ( Fischman Schuster , 1982 ) , in individuals with substance abuse histories .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   55 Self-administration_JJ_NN1 procedures_NN2 were_VBDR subsequently_RR applied_VVN_VVD to_II the_AT study_NN1 of_IO illicit_JJ drugs_NN2 ,_Y such_II21 as_II22 heroin_NN1 (_Y e.g._REX ,_Y Mello_NP1 Mendelson_NP1 ,_Y 1978_MC )_Y and_CC cocaine_NN1 (_Y Fischman_NP1 Schuster_NP1_NN1 ,_Y 1982_MC )_Y ,_Y in_II individuals_NN2 with_IW substance_NN1 abuse_NN1 histories_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   56 These procedures were soon adapted to investigate the ability of potential therapeutics to reduce drug taking , such as in the early work by Meyer , McNamee , Mirin , and Altman ( 1976 ) who investigated the ability of naltrexone to reduce opioid self-administration in heroin addiction .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   56 These_DD2 procedures_NN2 were_VBDR soon_RR adapted_VVN_VVD to_TO investigate_VVI the_AT ability_NN1 of_IO potential_JJ_NN1 therapeutics_NN1 to_TO reduce_VVI drug_NN1 taking_VVG ,_Y such_II21 as_II22 in_II the_AT early_JJ work_NN1 by_II Meyer_NP1 ,_Y McNamee_NP1 ,_Y Mirin_NP1_NN1 ,_Y and_CC Altman_NP1 (_Y 1976_MC )_Y who_PNQS investigated_VVD the_AT ability_NN1 of_IO naltrexone_NN1 to_TO reduce_VVI opioid_JJ self-administration_NN1 in_II heroin_NN1 addiction_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   57 Similarly , drug discrimination procedures were adapted for the human laboratory ( Chait , Uhlenhuth , Johanson , 1984 ; Preston , Bigelow , Bickel , Liebson , 1987 ) , thus providing the first opportunity to examine the relative concordance of discriminative stimulus effects and subjective descriptions ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   57 Similarly_RR ,_Y drug_NN1 discrimination_NN1 procedures_NN2 were_VBDR adapted_VVN for_IF the_AT human_JJ_NN1 laboratory_NN1 (_Y Chait_NP1_VV0_NN1 ,_Y Uhlenhuth_NP1_NN1 ,_Y Johanson_NP1 ,_Y 1984_MC ;_Y Preston_NP1 ,_Y Bigelow_NP1_VV0_NN1 ,_Y Bickel_NP1 ,_Y Liebson_NP1 ,_Y 1987_MC )_Y ,_Y thus_RR providing_VVG the_AT first_MD opportunity_NN1 to_TO examine_VVI the_AT relative_JJ_NN1 concordance_NN1 of_IO discriminative_JJ stimulus_NN1 effects_NN2 and_CC subjective_JJ descriptions_NN2 )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   58 The drug discrimination procedure has now been more broadly applied to the study of various drug classes in humans , including opioids , stimulants , and sedatives .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   58 The_AT drug_NN1 discrimination_NN1 procedure_NN1 has_VHZ now_RT been_VBN more_RGR broadly_RR applied_VVN_VVD to_II the_AT study_NN1 of_IO various_JJ drug_NN1 classes_NN2 in_II humans_NN2 ,_Y including_II_VVG@ opioids_NN2 ,_Y stimulants_NN2 ,_Y and_CC sedatives_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   59 These laboratory procedures also capitalized on the extensive body of clinical pharmacology research with drugs of abuse that had been conducted earlier , largely at the Federal Lexington Narcotics Prison Farm .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   59 These_DD2 laboratory_NN1 procedures_NN2 also_RR capitalized_VVD_VVN@ on_II the_AT extensive_JJ body_NN1 of_IO clinical_JJ pharmacology_NN1 research_NN1 with_IW drugs_NN2 of_IO abuse_NN1 that_CST had_VHD been_VBN conducted_VVN earlier_RRR ,_Y largely_RR at_II the_AT Federal_JJ Lexington_NN1@_NP1 Narcotics_NN2 Prison_NN1 Farm_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   60 Early investigators in this field developed empirically derived subjective questionnaires to characterize and categorize drug action ; these were incorporated into human behavioral pharmacology studies and are still in use ( e.g. , the Addiction Research Center Inventory short form , Martin , Sloan , Sapira , Jasinski , 1971 ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   60 Early_JJ_RR investigators_NN2 in_II this_DD1 field_NN1 developed_VVD_VVN empirically_RR derived_VVN_VVD subjective_JJ questionnaires_NN2 to_TO characterize_VVI and_CC categorize_VVI drug_NN1 action_NN1 ;_Y these_DD2 were_VBDR incorporated_VVN into_II human_JJ_NN1 behavioral_JJ_NN1 pharmacology_NN1 studies_NN2 and_CC are_VBR still_RR in_II use_NN1 (_Y e.g._REX ,_Y the_AT Addiction_NPX Research_NN1 Center_NN1 Inventory_NN1 short_JJ_RR@ form_NN1_VV0 ,_Y Martin_NP1 ,_Y Sloan_NP1_NN1 ,_Y Sapira_NP1 ,_Y Jasinski_NP1_NN1 ,_Y 1971_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   61 The basic principles of reinforcement have been extensively applied to the development of effective treatments for substance abuse in the field of contingency management , which employs specified reinforcers to increase the rate of therapeutically beneficial behaviors in substance abusers ( Higgins et al. , 1993 ; Silverman et al. , 2002 ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   61 The_AT basic_JJ principles_NN2 of_IO reinforcement_NN1 have_VH0 been_VBN extensively_RR applied_VVN_VVD to_II the_AT development_NN1 of_IO effective_JJ treatments_NN2 for_IF substance_NN1 abuse_NN1 in_II the_AT field_NN1 of_IO contingency_NN1 management_NN1 ,_Y which_DDQ employs_VVZ specified_JJ@ reinforcers_NN2 to_TO increase_VVI the_AT rate_NN1 of_IO therapeutically_RR beneficial_JJ behaviors_NN2 in_II substance_NN1 abusers_NN2 (_Y Higgins_NP1 et_RA21 al._RA22 ,_Y 1993_MC ;_Y Silverman_NP1 et_RA21 al._RA22 ,_Y 2002_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   62 Each of these areas of investigation was derived directly from the basic principles of behavioral pharmacology first revealed in the animal laboratory field of drug abuse liability assessment is one that has developed extensively over the past four decades ( Balster Bigelow , 2003 ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   62 Each_DD1 of_IO these_DD2 areas_NN2 of_IO investigation_NN1 was_VBDZ derived_VVN directly_RR from_II the_AT basic_JJ principles_NN2 of_IO behavioral_JJ_NN1 pharmacology_NN1 first_MD revealed_VVN_VVD in_II the_AT animal_NN1 laboratory_NN1 field_NN1 of_IO drug_NN1 abuse_NN1 liability_NN1 assessment_NN1 is_VBZ one_PN1 that_CST has_VHZ developed_VVN extensively_RR over_II_RP the_AT past_JJ four_MC decades_NNT2 (_Y Balster_NP1 Bigelow_NP1_NN1 ,_Y 2003_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   63 Behavioral pharmacological methods , such as drug self-administration and drug discrimination , lie at its core .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   63 Behavioral_JJ pharmacological_JJ methods_NN2 ,_Y such_II21 as_II22 drug_NN1 self-administration_NN1 and_CC drug_NN1 discrimination_NN1 ,_Y lie_VV0 at_II its_Z' core_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   64 Conceptually similar methods are used in animals and humans ( Balster , 1991 ; Brady Griffiths , 1976 ; Fischman Mello , 1989 ) , with substantial cross-species and cross-drug commonality in assessment methods .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   64 Conceptually_RR similar_JJ methods_NN2 are_VBR used_VVN in_II animals_NN2 and_CC humans_NN2 (_Y Balster_NP1_NN1 ,_Y 1991_MC ;_Y Brady_NP1 Griffiths_NP1 ,_Y 1976_MC ;_Y Fischman_NP1 Mello_NP1 ,_Y 1989_MC )_Y ,_Y with_IW substantial_JJ cross-species_NN_JJ and_CC cross-drug_JJ_NN1 commonality_NN1 in_II assessment_NN1 methods_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   65 The methods have become considerably more sophisticated over the years - moving from methods that provided largely categorical answers ( " Is this drug self-administered ?
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   65 The_AT methods_NN2 have_VH0 become_VVN@ considerably_RR more_RGR sophisticated_JJ over_II the_AT years_NNT2 -_- moving_VVG from_II methods_NN2 that_CST provided_CS_VVD largely_RR categorical_JJ answers_NN2 (_Y "_Y Is_VBZ this_DD1 drug_NN1 self-administered_NN1 ?_Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   66 " ) to using more fine-grained choice and progressive ratio and behavioral economic assessments that can better evaluate and rank order drugs in terms of their reinforcing effectiveness , robustness , and overall abuse liability .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   66 "_Y )_Y to_II using_VVG more_RGR fine-grained_JJ choice_NN1 and_CC progressive_JJ ratio_NN1 and_CC behavioral_JJ economic_JJ assessments_NN2 that_CST_DD1 can_VM better_RRR evaluate_VVI and_CC rank_VVI order_NN1 drugs_NN2 in_II31 terms_II32 of_II33 their_APPGE reinforcing_JJ@ effectiveness_NN1 ,_Y robustness_NN1 ,_Y and_CC overall_JJ_NN1 abuse_NN1 liability_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   67 <p> These assessment methods of abuse liability have also been adapted for testing potential pharmacotherapies to determine whether they reduce the effects , self-administration , and apparent abuse liability of their targeted drug of abuse .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   67 <p>_Y These_DD2 assessment_NN1 methods_NN2 of_IO abuse_NN1 liability_NN1 have_VH0 also_RR been_VBN adapted_VVN for_IF testing_VVG potential_JJ_NN1 pharmacotherapies_NN2 to_TO determine_VVI whether_CSW they_PPHS2 reduce_VV0 the_AT effects_NN2 ,_Y self-administration_NN1_JJ ,_Y and_CC apparent_JJ abuse_NN1 liability_NN1 of_IO their_APPGE targeted_JJ% drug_NN1 of_IO abuse_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   68 These methods , in both animal and human laboratories , have the potential to promising and deserve further evaluation in large-scale clinical trials .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   68 These_DD2 methods_NN2 ,_Y in_II_RP@ both_RR animal_NN1_JJ% and_CC human_JJ_NN1 laboratories_NN2 ,_Y have_VH0 the_AT potential_JJ_NN1 to_TO promising_JJ and_CC deserve_VV0 further_JJR@_RRR evaluation_NN1 in_II large-scale_JJ clinical_JJ trials_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   69 <p> Methadone , buprenorphine , and naltrexone are the drug addiction pharmacotherapy development success stories of the past decades ( Vocci Ling , 2005 ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   69 <p>_Y Methadone_VV0_NN1_NP1@ ,_Y buprenorphine_VV0_NN1 ,_Y and_CC naltrexone_NN1_VV0 are_VBR the_AT drug_NN1 addiction_NN1 pharmacotherapy_NN1 development_NN1 success_NN1 stories_NN2 of_IO the_AT past_JJ_NN1 decades_NNT2 (_Y Vocci_NP1_JJ_NN1 Ling_NN1 ,_Y 2005_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   70 Methadone achieved its adoption and success through the clinical innovation of Dole and Nyswander without extensive prior laboratory research indicating its use for addiction ( Dole Nyswander , 1965 ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   70 Methadone_NP1@_NN1_VV0 achieved_VVD its_Z' adoption_NN1 and_CC success_NN1 through_II the_AT clinical_JJ innovation_NN1 of_IO Dole_NP1 and_CC Nyswander_VV0_NN1_NP1 without_IW extensive_JJ prior_JJ laboratory_NN1 research_NN1 indicating_VVG its_Z' use_NN1 for_IF addiction_NN1 (_Y Dole_NP1 Nyswander_NP1 ,_Y 1965_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   71 Buprenorphine and naltrexone , on the other hand , have both been developed through sequential animal and human laboratory studies followed by subsequent clinical trials .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   71 Buprenorphine_VV0_NN1_NP1@ and_CC naltrexone_NN1_VV0 ,_Y on_II the_AT other_JJ hand_NN1 ,_Y have_VH0 both_RR been_VBN developed_VVN through_II sequential_JJ animal_NN1 and_CC human_JJ_NN1 laboratory_NN1 studies_NN2 followed_VVN by_II subsequent_JJ clinical_JJ trials_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   72 All three are pharmacological wonder drugs , with great efficacy in interrupting addictive processes , but none has yet been fully embraced into clinical practice .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   72 All_DB three_MC are_VBR pharmacological_JJ wonder_NN1_JJ@ drugs_NN2 ,_Y with_IW great_JJ efficacy_NN1 in_II interrupting_VVG addictive_JJ processes_NN2 ,_Y but_CCB none_PN has_VHZ yet_RR been_VBN fully_RR embraced_VVN_VVD into_II clinical_JJ practice_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   73 Both methadone and naltrexone continue to struggle for community acceptance .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   73 Both_RR methadone_VV0 and_CC naltrexone_VV0_NN1 continue_VV0 to_TO struggle_VVI for_IF community_NN1 acceptance_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   74 Buprenorphine is the newcomer to addiction treatment .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   74 Buprenorphine_NN1_VV0_NP1@ is_VBZ the_AT newcomer_NN1 to_II addiction_NN1 treatment_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   75 Its degree of acceptance may determine the willingness of pharmaceutical companies to invest in the development of addiction treatments .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   75 Its_Z' degree_NN1 of_IO acceptance_NN1 may_VM determine_VVI the_AT willingness_NN1 of_IO pharmaceutical_JJ companies_NN2 to_TO invest_VVI in_II the_AT development_NN1 of_IO addiction_NN1 treatments_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   76 Buprenorphine is especially interesting , since its primary marketed dosage form ( the buprenorphinenaloxone combination ) is an engineered dosage form specifically designed to incorporate reinforcement and punishment to encourage appropriate 2003 ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   76 Buprenorphine_NN1_VV0_NP1@ is_VBZ especially_RR interesting_JJ ,_Y since_CS its_Z' primary_NN1 marketed_VVD_VVN dosage_NN1 form_NN1 (_Y the_AT buprenorphinenaloxone_NN1 combination_NN1 )_Y is_VBZ an_AT1 engineered_JJ dosage_NN1 form_NN1_VV0 specifically_RR designed_VVN_VVD to_TO incorporate_VVI reinforcement_NN1 and_CC punishment_NN1 to_TO encourage_VVI appropriate_JJ 2003_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   77 If the medication is taken as directed , only the reinforcing buprenorphine achieves significant biodelivery .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   77 If_CS the_AT medication_NN1 is_VBZ taken_VVN as_CSA directed_VVN ,_Y only_RR the_AT reinforcing_JJ@ buprenorphine_NN1 achieves_VVZ significant_JJ biodelivery_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   78 However , if taken inappropriately ( i.e. , by injection ) , the antagonist naloxone , portion is fully delivered and can precipitate an aversive withdrawal reaction in dependent individuals ( Stoller , Bigelow , Walsh , Strain , 2001 ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   78 However_RR ,_Y if_CS taken_VVN inappropriately_RR (_Y i.e._REX ,_Y by_II injection_NN1 )_Y ,_Y the_AT antagonist_NN1 naloxone_NN1_VV0 ,_Y portion_NN1 is_VBZ fully_RR delivered_VVN_VVD and_CC can_VM precipitate_VVI an_AT1 aversive_JJ withdrawal_NN1 reaction_NN1 in_II dependent_JJ individuals_NN2 (_Y Stoller_NP1_NN1 ,_Y Bigelow_NP1_VV0_NN1 ,_Y Walsh_NP1 ,_Y Strain_VV0_NN1_NP1@ ,_Y 2001_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   79 <p> The value of behavioral pharmacology to the substance abuse field is reflected in part by the growth of behavioral pharmacology research , it is also reflected in the use of behavioral pharmacological methods by other disciplinary approaches to studying substance abuse and addiction .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   79 <p>_Y The_AT value_NN1 of_IO behavioral_JJ_NN1 pharmacology_NN1 to_II the_AT substance_NN1 abuse_NN1 field_NN1 is_VBZ reflected_VVN in_RR21 part_RR22 by_II the_AT growth_NN1 of_IO behavioral_JJ_NN1 pharmacology_NN1 research_NN1 ,_Y it_PPH1 is_VBZ also_RR reflected_VVN_VVD in_II the_AT use_NN1 of_IO behavioral_JJ pharmacological_JJ methods_NN2 by_II other_JJ disciplinary_JJ approaches_NN2 to_II studying_VVG substance_NN1 abuse_NN1 and_CC addiction_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   80 For example , such methods as drug discrimination and drug self-administration have become widely used as tools in neurobiology and neuroscience research on addiction ( Koob Le Moal , 2006 ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   80 For_REX21 example_REX22 ,_Y such_DA methods_NN2 as_CSA drug_NN1 discrimination_NN1 and_CC drug_NN1 self-administration_NN1 have_VH0 become_VVN@ widely_RR used_VVN_VVD_JJ as_CSA_II@ tools_NN2 in_II neurobiology_NN1 and_CC neuroscience_NN1 research_NN1 on_II addiction_NN1 (_Y Koob_NP1 Le_NP1 Moal_NP1 ,_Y 2006_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   81 <p> Behavioral pharmacological understanding of drug abuse and addiction has had a significant impact on clinical therapeutics and clinical trials .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   81 <p>_Y Behavioral_JJ pharmacological_JJ understanding_NN1 of_IO drug_NN1 abuse_NN1 and_CC addiction_NN1 has_VHZ had_VHN a_AT1 significant_JJ impact_NN1 on_II clinical_JJ therapeutics_NN1 and_CC clinical_JJ trials_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   82 For all varieties of addictive disorders , the most common treatment is counseling based on cognitive behavioral procedures that emphasize the risks posed by drug-related environmental stimulus conditions , the and the importance of motivational or incentive-based approaches for discouraging drug use and for encouraging competing alternative behaviors .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   82 For_IF all_DB varieties_NN2 of_IO addictive_JJ disorders_NN2 ,_Y the_AT most_RGT common_JJ treatment_NN1 is_VBZ counseling_NN1 based_VVN on_II cognitive_JJ behavioral_JJ_NN1 procedures_NN2 that_CST emphasize_VV0 the_AT risks_NN2 posed_VVN by_II drug-related_JJ environmental_JJ stimulus_NN1 conditions_NN2 ,_Y the_AT and_CC the_AT importance_NN1 of_IO motivational_JJ or_CC incentive-based_JJ_NN1 approaches_NN2_VVZ for_IF discouraging_JJ_VVG drug_NN1 use_NN1 and_CC for_IF encouraging_JJ_VVG@ competing_JJ alternative_JJ_NN1 behaviors_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   83 This type of cognitive-behavioral treatment is now widely accepted as the appropriate psychosocial treatment platform for conducting clinical trials of potential pharmacotherapies for addictive disorders ( Carroll Onken , 2005 ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   83 This_DD1 type_NN1 of_IO cognitive-behavioral_JJ_NN1 treatment_NN1 is_VBZ now_RT widely_RR accepted_VVN as_II_CSA the_AT appropriate_JJ psychosocial_JJ treatment_NN1 platform_NN1 for_IF conducting_VVG clinical_JJ trials_NN2 of_IO potential_JJ_NN1 pharmacotherapies_NN2 for_IF addictive_JJ disorders_NN2 (_Y Carroll_NP1 Onken_NP1 ,_Y 2005_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   84 <p> Contingency management is another treatment approach that has proven effective for reducing drug use across multiple substance use disorders .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   84 <p>_Y Contingency_NN1 management_NN1 is_VBZ another_DD1 treatment_NN1 approach_NN1_VV0@ that_CST_DD1 has_VHZ proven_VVN effective_JJ for_IF reducing_VVG_JJ@ drug_NN1 use_NN1_VV0 across_II multiple_JJ_NN1 substance_NN1 use_NN1_VV0 disorders_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   85 This approach capitalizes on the stimulus-response relationship by using clinically relevant reinforcers to increase the rate of desired behaviors .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   85 This_DD1 approach_NN1 capitalizes_VVZ on_II the_AT stimulus-response_JJ_NN1 relationship_NN1 by_II using_VVG clinically_RR relevant_JJ reinforcers_NN2 to_TO increase_VVI the_AT rate_NN1 of_IO desired_JJ@ behaviors_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   86 Early contingency management studies conducted with opioid addicts maintained on methadone demonstrated that an array of reinforcers , such as small dose increases , take-home doses , and monetary payments , could be used to increase the rate of target behaviors , including drug abstinence , attendance , and fee payments ( Stitzer , Bigelow , Liebson , 1979 , 1984 ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   86 Early_JJ contingency_NN1 management_NN1 studies_NN2 conducted_VVN_VVD with_IW opioid_JJ addicts_NN2 maintained_VVN_VVD on_II methadone_NN1 demonstrated_VVD_VVN that_CST an_AT1 array_NN1 of_IO reinforcers_NN2 ,_Y such_II21 as_II22 small_JJ dose_NN1 increases_NN2_VVZ ,_Y take-home_JJ doses_NN2 ,_Y and_CC monetary_JJ payments_NN2 ,_Y could_VM be_VBI used_VVN to_TO increase_VVI the_AT rate_NN1 of_IO target_NN1 behaviors_NN2 ,_Y including_II_VVG@ drug_NN1 abstinence_NN1 ,_Y attendance_NN1 ,_Y and_CC fee_NN1 payments_NN2 (_Y Stitzer_NP1 ,_Y Bigelow_NP1_VV0_NN1 ,_Y Liebson_NP1 ,_Y 1979_MC ,_Y 1984_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   87 Alternatively , punishment could be used ( e.g. , contingent dose decreases or treatment termination ) to suppress undesired behaviors ( e.g. , illicit drug use ) ( Stitzer , Bigelow , Liebson have been developed to sustain behaviors by using schedules of reinforcement where the magnitude of reinforcer ( i.e. , typically money or vouchers exchangeable for goods and services ) escalates with repeated desired responses ( e.g. , consecutive days of abstinence ) ( Higgins , Alessi , Dantona , 2002 ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   87 Alternatively_RR ,_Y punishment_NN1 could_VM be_VBI used_VVN (_Y e.g._REX ,_Y contingent_JJ_NN1 dose_NN1 decreases_VVZ_NN2@ or_CC treatment_NN1 termination_NN1 )_Y to_TO suppress_VVI undesired_JJ behaviors_NN2 (_Y e.g._REX ,_Y illicit_JJ drug_NN1 use_NN1 )_Y (_Y Stitzer_NP1 ,_Y Bigelow_NP1_VV0_NN1 ,_Y Liebson_NP1 have_VH0 been_VBN developed_VVN to_TO sustain_VVI behaviors_NN2 by_II using_VVG schedules_NN2 of_IO reinforcement_NN1 where_CS_RRQ the_AT magnitude_NN1 of_IO reinforcer_NN1 (_Y i.e._REX ,_Y typically_RR money_NN1 or_CC vouchers_NN2 exchangeable_JJ for_IF goods_NN2 and_CC services_NN2 )_Y escalates_VVZ with_IW repeated_JJ@ desired_JJ@ responses_NN2 (_Y e.g._REX ,_Y consecutive_JJ days_NNT2 of_IO abstinence_NN1 )_Y (_Y Higgins_NP1 ,_Y Alessi_NP1_NN1 ,_Y Dantona_NP1 ,_Y 2002_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   88 The contingency management voucher procedures have demonstrated efficacy across substance use disorders and treatment environments , which has led to their adoption in clinical practice settings ( Stitzer Vandrey , 2008 ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   88 The_AT contingency_NN1 management_NN1 voucher_NN1 procedures_NN2 have_VH0 demonstrated_VVN efficacy_NN1 across_II substance_NN1 use_NN1_VV0 disorders_NN2 and_CC treatment_NN1 environments_NN2 ,_Y which_DDQ has_VHZ led_VVN to_II their_APPGE adoption_NN1 in_II clinical_JJ practice_NN1 settings_NN2 (_Y Stitzer_NP1 Vandrey_NP1 ,_Y 2008_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   89 <p> Another creative advance in the field has been the application of economic principles to behavioral pharmacology .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   89 <p>_Y Another_DD1 creative_JJ advance_NN1 in_II the_AT field_NN1 has_VHZ been_VBN the_AT application_NN1 of_IO economic_JJ principles_NN2 to_II behavioral_JJ_NN1 pharmacology_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   90 Behavioral economics has provided a theoretical construct to understand the relationship of data collected across different effective procedures on the relative reinforcing efficacy of drugs of abuse .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   90 Behavioral_JJ_NN1 economics_NN1 has_VHZ provided_VVN a_AT1 theoretical_JJ construct_VV0_NN1% to_TO understand_VVI the_AT relationship_NN1 of_IO data_NN collected_VVN_VVD across_II different_JJ effective_JJ procedures_NN2 on_II the_AT relative_JJ_NN1 reinforcing_JJ@_VVG efficacy_NN1 of_IO drugs_NN2 of_IO abuse_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   91 By examining traditional outcome measures , such as response rate , as economic indices of maximal output and demand , previously disparate results become orderly and understandable as a mathematical function within this new framework ( Bickel , Marsch , Carroll , 2000 ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   91 By_II examining_VVG traditional_JJ outcome_NN1 measures_NN2 ,_Y such_II21 as_II22 response_NN1 rate_NN1 ,_Y as_CSA_RG@ economic_JJ indices_NN2 of_IO maximal_JJ output_NN1 and_CC demand_NN1_VV0 ,_Y previously_RR disparate_JJ results_NN2 become_VV0 orderly_JJ and_CC understandable_JJ as_II_CSA a_AT1 mathematical_JJ function_NN1 within_II this_DD1 new_JJ framework_NN1 (_Y Bickel_NP1 ,_Y Marsch_NP1_NN1 ,_Y Carroll_NP1 ,_Y 2000_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   92 Behavioral economics has also introduced the concept of delay discounting , a as the time to their anticipated delivery is increased ( Bickel Marsch , 2001 ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   92 Behavioral_JJ_NN1 economics_NN1 has_VHZ also_RR introduced_VVN the_AT concept_NN1 of_IO delay_NN1 discounting_NN1_VVG ,_Y a_AT1 as_II_CSA the_AT time_NNT1 to_II their_APPGE anticipated_JJ delivery_NN1 is_VBZ increased_VVN_JJ (_Y Bickel_NP1 Marsch_NP1 ,_Y 2001_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   93 Numerous studies have been conducted using the delay discounting procedures to gain a better understanding of how changes in reinforcer magnitude and delay of reinforcement affect the choice to use drugs .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   93 Numerous_JJ studies_NN2 have_VH0 been_VBN conducted_VVN using_VVG the_AT delay_NN1 discounting_NN1_VVG procedures_NN2 to_TO gain_VVI a_AT1 better_JJR understanding_NN1 of_IO how_RRQ changes_NN2 in_II reinforcer_NN1 magnitude_NN1 and_CC delay_NN1 of_IO reinforcement_NN1 affect_VV0_NN1 the_AT choice_NN1 to_TO use_VVI drugs_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   94 Individual differences in delay-discounting behavior have been used as an experimental proxy for impulsivity--providing a quantitative framework for measurement of choice behavior as a function of a preexisting personality trait .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   94 Individual_JJ_NN1 differences_NN2 in_II delay-discounting_JJ_NN1 behavior_NN1 have_VH0 been_VBN used_VVN as_II an_AT1 experimental_JJ proxy_NN1 for_IF impulsivity--providing_NN1_JJ a_AT1 quantitative_JJ framework_NN1 for_IF measurement_NN1 of_IO choice_NN1_JJ@ behavior_NN1 as_II_CSA a_AT1 function_NN1 of_IO a_AT1 preexisting_JJ@_NN1@ personality_NN1 trait_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   95 <p> The importance and contributions of behavioral pharmacological science are also reflected in our national history with tobacco over the past few decades .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   95 <p>_Y The_AT importance_NN1 and_CC contributions_NN2 of_IO behavioral_JJ pharmacological_JJ science_NN1 are_VBR also_RR reflected_VVN_VVD in_II our_APPGE national_JJ history_NN1 with_IW tobacco_NN1 over_II the_AT past_JJ_NN1 few_DA2 decades_NNT2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   96 The 1988 Surgeon General 's Report on Tobacco Addiction ( USDHEW , 1988 ) , followed by more recent revelations that the tobacco industry understood the addictive characteristics of tobacco , and used marketing to promote addiction while publicly denying that this was the case , transformed our national tobacco policy .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   96 The_AT 1988_MC Surgeon_NN1 General_NN1 's_GE Report_NN1 on_II Tobacco_NN1 Addiction_NPX (_Y USDHEW_NP1_VV0_NN1 ,_Y 1988_MC )_Y ,_Y followed_VVN by_II more_RGR_DAR recent_JJ revelations_NN2 that_CST the_AT tobacco_NN1 industry_NN1 understood_VVD_VVN the_AT addictive_JJ characteristics_NN2 of_IO tobacco_NN1 ,_Y and_CC used_JJ_VVD marketing_NN1 to_TO promote_VVI addiction_NN1 while_CS publicly_RR denying_VVG that_CST this_DD1 was_VBDZ the_AT case_NN1 ,_Y transformed_VVD_VVN our_APPGE national_JJ tobacco_NN1 policy_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   97 This transformation was built on a foundation of behavioral pharmacological research on tobacco and tobacco dependence ( Henningfield Fant , 1999 ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   97 This_DD1 transformation_NN1 was_VBDZ built_VVN on_II a_AT1 foundation_NN1 of_IO behavioral_JJ pharmacological_JJ research_NN1 on_II tobacco_NN1 and_CC tobacco_NN1 dependence_NN1 (_Y Henningfield_NP1 Fant_NP1 ,_Y 1999_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   98 <p> L : CHALLENGES AND OPPORTUNITIES FOR BEHAVIORAL PHARMACOLOGY RESEARCH IN drug use well , but falls short of defining pathological forms of drug abuse .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   98 <p>_Y L_ZZ1_NP1@ :_Y CHALLENGES_NN2 AND_CC OPPORTUNITIES_NN2 FOR_IF BEHAVIORAL_JJ_NP1 PHARMACOLOGY_NN1_NP1 RESEARCH_NN1 IN_II drug_NN1 use_NN1_VV0 well_RR_NN1@ ,_Y but_CCB falls_VVZ short_JJ_RR@ of_IO defining_VVG pathological_JJ forms_NN2 of_IO drug_NN1 abuse_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0   99 This challenge comes from the view that some qualitative difference exists between the principles that apply to use and abuse ( i.e. , that a " switch " exists that results in drug abuse disorders ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0   99 This_DD1 challenge_NN1 comes_VVZ from_II the_AT view_NN1 that_CST some_DD qualitative_JJ difference_NN1 exists_VVZ between_II the_AT principles_NN2 that_CST apply_VV0 to_TO use_VVI and_CC abuse_NN1 (_Y i.e._REX ,_Y that_CST a_AT1 "_Y switch_NN1 "_Y exists_VVZ that_CST results_NN2_VVZ@ in_II drug_NN1 abuse_NN1 disorders_NN2 )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  100 Various lines of investigation have been developed to address this concern , many of which incorporate brain biology into a more comprehensive theory of drug abuse ( Koob Le Moal , 2006 ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  100 Various_JJ lines_NN2 of_IO investigation_NN1 have_VH0 been_VBN developed_VVN to_TO address_VVI this_DD1 concern_NN1 ,_Y many_DA2 of_IO which_DDQ incorporate_VV0 brain_NN1 biology_NN1 into_II a_AT1 more_RGR comprehensive_JJ theory_NN1 of_IO drug_NN1 abuse_NN1 (_Y Koob_NP1 Le_NP1 Moal_NP1 ,_Y 2006_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  101 These lines of investigation also incorporate measures of mood ( e.g. , hedonic dysregulation ) , cognitive processing ( e.g. , craving ) , and the role of character traits ( e.g. , risk-taking or impulsivity ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  101 These_DD2 lines_NN2 of_IO investigation_NN1 also_RR incorporate_VV0 measures_NN2 of_IO mood_NN1 (_Y e.g._REX ,_Y hedonic_JJ dysregulation_NN1 )_Y ,_Y cognitive_JJ processing_NN1 (_Y e.g._REX ,_Y craving_VVG )_Y ,_Y and_CC the_AT role_NN1 of_IO character_NN1 traits_NN2 (_Y e.g._REX ,_Y risk-taking_JJ_NN1 or_CC impulsivity_NN1 )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  102 It is too soon to know if this variation on behavioral pharmacology will yield insights into addiction that will result in novel therapies .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  102 It_PPH1 is_VBZ too_RG soon_RR to_TO know_VVI if_CSW@_CS this_DD1 variation_NN1 on_II behavioral_JJ_NN1 pharmacology_NN1 will_VM yield_VVI insights_NN2 into_II addiction_NN1 that_CST_DD1 will_VM result_VVI in_II novel_JJ_NN1 therapies_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  103 From the perspective of animal research , much research on the development of drug abuse has reverted to indirect measures of abuse-related phenomena , such as sensitization of locomotor behavior ( Nelson Kilcross , 2006 ; Robinson Berridge , 1993 2007 ; Koob , 1992 ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  103 From_II the_AT perspective_NN1 of_IO animal_NN1 research_NN1 ,_Y much_DA1_RR research_NN1_VV0@ on_II the_AT development_NN1 of_IO drug_NN1 abuse_NN1 has_VHZ reverted_VVN to_II indirect_JJ measures_NN2 of_IO abuse-related_JJ_NN1 phenomena_NN2 ,_Y such_II21 as_II22 sensitization_NN1 of_IO locomotor_NN1 behavior_NN1 (_Y Nelson_NP1 Kilcross_NP1 ,_Y 2006_MC ;_Y Robinson_NP1 Berridge_NP1 ,_Y 1993_MC 2007_MC ;_Y Koob_NP1 ,_Y 1992_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  104 Perhaps an important direction would be to retain the complexity of behavioral pharmacology models of addiction while looking for systematic qualitative changes in behaviors that reflect the addiction process .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  104 Perhaps_RR an_AT1 important_JJ direction_NN1 would_VM be_VBI to_TO retain_VVI the_AT complexity_NN1 of_IO behavioral_JJ_NN1 pharmacology_NN1 models_NN2 of_IO addiction_NN1 while_CS looking_VVG for_IF systematic_JJ qualitative_JJ changes_NN2 in_II behaviors_NN2 that_CST reflect_VV0 the_AT addiction_NN1 process_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  105 In addition , developing animal models for the reinstatement of drug self-administration holds great promise for studying relapse ( Shaham , Shalev , Lu , De Wit , Stewarti 2003 ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  105 In_RR21 addition_RR22 ,_Y developing_JJ_VVG animal_NN1 models_NN2 for_IF the_AT reinstatement_NN1 of_IO drug_NN1 self-administration_NN1 holds_VVZ great_JJ promise_NN1 for_IF studying_VVG relapse_NN1 (_Y Shaham_NP1 ,_Y Shalev_NP1 ,_Y Lu_NP1_NN1 ,_Y De_NP1 Wit_NN1 ,_Y Stewarti_NP1_NN1_JJ 2003_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  106 It should be noted that one of the symptoms of drug abuse that drives this concept of a disease process is self-control .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  106 It_PPH1 should_VM be_VBI noted_VVN that_CST one_MC1 of_IO the_AT symptoms_NN2 of_IO drug_NN1 abuse_NN1_VV0@ that_CST_DD1 drives_VVZ this_DD1 concept_NN1 of_IO a_AT1 disease_NN1 process_NN1 is_VBZ self-control_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  107 Addicts are often described as out of control and compulsive .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  107 Addicts_NN2 are_VBR often_RR described_VVN as_CSA out_II21 of_II22 control_NN1 and_CC compulsive_JJ ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  108 Indeed , psychiatric criteria for diagnosis of drug dependence , as opposed to drug abuse , tend to rely on endorsement of specific symptoms or behaviors related to the loss of control , such as " a persistent desire or unsuccessful efforts to cut down or control substance use " ( American Psychiatric Association , 2000 , p. 197 ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  108 Indeed_RR ,_Y psychiatric_JJ criteria_NN2 for_IF diagnosis_NN1 of_IO drug_NN1 dependence_NN1 ,_Y as_II31 opposed_II32 to_II33 drug_NN1 abuse_NN1 ,_Y tend_VV0 to_TO rely_VVI on_II endorsement_NN1 of_IO specific_JJ symptoms_NN2 or_CC behaviors_NN2 related_VVN_VVD to_II the_AT loss_NN1 of_IO control_NN1 ,_Y such_II21 as_II22 "_Y a_AT1 persistent_JJ desire_NN1 or_CC unsuccessful_JJ efforts_NN2 to_TO cut_VVI down_RP or_CC control_NN1_VV0 substance_NN1 use_NN1 "_Y (_Y American_JJ Psychiatric_JJ Association_NN1 ,_Y 2000_MC ,_Y p._NN1_NNU 197_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  109 Behavioral pharmacology research challenges this concept .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  109 Behavioral_JJ_NN1 pharmacology_NN1 research_NN1 challenges_VVZ@_NN2 this_DD1 concept_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  110 Most research shows that even the most pathological forms of drug-taking behavior in animals and humans is actually well-controlled Bickel Marsch , 2001 ; Higgins , Bickel , Hughes , 1994 ) , just not by the most desirable variables .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  110 Most_DAT research_NN1 shows_VVZ that_CST even_RR the_AT most_RGT pathological_JJ forms_NN2 of_IO drug-taking_NN1 behavior_NN1 in_II animals_NN2 and_CC humans_NN2 is_VBZ actually_RR well-controlled_JJ_NN1 Bickel_NP1 Marsch_NP1 ,_Y 2001_MC ;_Y Higgins_NP1 ,_Y Bickel_NP1 ,_Y Hughes_NP1 ,_Y 1994_MC )_Y ,_Y just_RR not_XX by_II the_AT most_RGT desirable_JJ variables_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  111 For example , even modest payments for clean urine samples can result in considerable behavioral changes in individuals with severe drug abuse problems ( Petry Martin , 2002 ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  111 For_REX21 example_REX22 ,_Y even_RR modest_JJ payments_NN2 for_IF clean_JJ urine_NN1 samples_NN2 can_VM result_VVI in_II considerable_JJ behavioral_JJ_NN1 changes_NN2 in_II individuals_NN2 with_IW severe_JJ drug_NN1 abuse_NN1 problems_NN2 (_Y Petry_NP1 Martin_NP1 ,_Y 2002_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  112 <p> Behavioral pharmacology research has not fully explored genetics .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  112 <p>_Y Behavioral_JJ_NN1 pharmacology_NN1 research_NN1 has_VHZ not_XX fully_RR explored_VVN genetics_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  113 Behavioral psychology and behavioral pharmacology have tended to minimize the roles of genetics and inherited individual differences .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  113 Behavioral_JJ_NN1 psychology_NN1 and_CC behavioral_JJ_NN1 pharmacology_NN1 have_VH0 tended_VVN to_TO minimize_VVI the_AT roles_NN2 of_IO genetics_NN1 and_CC inherited_VVD_VVN_JJ@ individual_JJ differences_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  114 In general , the behavioral view of addiction has been far onto the " nurture " end of the nature-nurture continuum , taking the view that vulnerability to addiction is universal and that the major determinants of addictive behavior lie in environmental conditions and in experiential learning .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  114 In_RR21 general_RR22 ,_Y the_AT behavioral_JJ_NN1 view_NN1 of_IO addiction_NN1 has_VHZ been_VBN far_RR_JJ onto_II the_AT "_Y nurture_NN1 "_Y end_NN1 of_IO the_AT nature-nurture_JJ continuum_NN1 ,_Y taking_VVG the_AT view_NN1 that_CST_DD1 vulnerability_NN1 to_II addiction_NN1 is_VBZ universal_JJ and_CC that_CST the_AT major_JJ determinants_NN2 of_IO addictive_JJ behavior_NN1 lie_VV0_NN1@ in_II_RP@ environmental_JJ conditions_NN2 and_CC in_II experiential_JJ learning_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  115 However , extensive data--both animal and human--make clear that genetics play an important role in addiction vulnerability and risk ( Belknap , Metten , Beckley , Crabbe , 2008 ; Kreek , Nielsen , LaForge , 2004 ; Uhl , 2004 ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  115 However_RR ,_Y extensive_JJ data--both_RR animal_NN1_JJ% and_CC human--make_JJ clear_JJ that_CST_DD1 genetics_NN1 play_VV0_NN1 an_AT1 important_JJ role_NN1 in_II addiction_NN1 vulnerability_NN1 and_CC risk_NN1_VV0 (_Y Belknap_NP1_VV0_NN1 ,_Y Metten_NP1_VV0 ,_Y Beckley_NP1 ,_Y Crabbe_NP1 ,_Y 2008_MC ;_Y Kreek_NP1 ,_Y Nielsen_NP1 ,_Y LaForge_NP1_VV0_NN1 ,_Y 2004_MC ;_Y Uhl_NP1 ,_Y 2004_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  116 The need for high throughput phenotyping for behavioral genetics research has led to some abandonment implications of this backward step in animal modeling have yet to be determined .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  116 The_AT need_NN1 for_IF high_JJ throughput_NN1 phenotyping_VVG for_IF behavioral_JJ_NN1 genetics_NN1 research_NN1 has_VHZ led_VVN to_II some_DD abandonment_NN1 implications_NN2 of_IO this_DD1 backward_JJ step_NN1 in_II animal_NN1 modeling_NN1 have_VH0 yet_RR to_TO be_VBI determined_VVN ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  117 A similar problem exists for defining phenotypes for genetic studies in humans .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  117 A_AT1_ZZ1 similar_JJ problem_NN1 exists_VVZ for_IF defining_VVG_JJ@ phenotypes_NN2 for_IF genetic_JJ studies_NN2 in_II humans_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  118 Measured patterns of behavior are rarely used .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  118 Measured_JJ@_VVN patterns_NN2 of_IO behavior_NN1 are_VBR rarely_RR used_VVN_VVD_JJ ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  119 Instead , phenotypes derived from epidemiology , such as " ever used " or meeting a diagnostic criterion for dependence , dominate this field .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  119 Instead_RR ,_Y phenotypes_NN2 derived_VVN from_II epidemiology_NN1 ,_Y such_II21 as_II22 "_Y ever_RR used_VVN_JJ_VVD "_Y or_CC meeting_VVG a_AT1 diagnostic_JJ criterion_NN1 for_IF dependence_NN1 ,_Y dominate_VV0 this_DD1 field_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  120 Again , the problem is , in part , the result of the large numbers of subjects needed for association and linkage studies , making careful measurement of behavior impractical .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  120 Again_RT ,_Y the_AT problem_NN1 is_VBZ ,_Y in_RR21 part_RR22 ,_Y the_AT result_NN1 of_IO the_AT large_JJ numbers_NN2 of_IO subjects_NN2 needed_VVN_VVD for_IF association_NN1 and_CC linkage_NN1 studies_NN2 ,_Y making_VVG careful_JJ measurement_NN1 of_IO behavior_NN1 impractical_JJ ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  121 We are at the early stages of learning the role genes play in addiction , and the full story is likely to be quite complex .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  121 We_PPIS2 are_VBR at_II the_AT early_JJ stages_NN2 of_IO learning_VVG the_AT role_NN1 genes_NN2 play_VV0 in_II_RP@ addiction_NN1 ,_Y and_CC the_AT full_JJ story_NN1 is_VBZ likely_JJ to_TO be_VBI quite_RG complex_JJ ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  122 It appears some genetic risk factors are drug-specific ( i.e. , opioid versus alcohol versus tobacco dependence ) and some non-specific ( i.e. , perhaps more like a personality-related vulnerability factor ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  122 It_PPH1 appears_VVZ some_DD genetic_JJ risk_NN1 factors_NN2 are_VBR drug-specific_JJ (_Y i.e._REX ,_Y opioid_NN1_JJ versus_II alcohol_NN1 versus_II tobacco_NN1 dependence_NN1 )_Y and_CC some_DD non-specific_JJ (_Y i.e._REX ,_Y perhaps_RR more_RRR_DAR like_II a_AT1 personality-related_JJ_NN1 vulnerability_NN1 factor_NN1 )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  123 It also appears that separate genetic risk factors may be related to the initiation of substance use experimentation versus the progression from use to abuse and dependence .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  123 It_PPH1 also_RR appears_VVZ that_CST separate_VV0_JJ genetic_JJ risk_NN1 factors_NN2 may_VM be_VBI related_VVN to_II the_AT initiation_NN1 of_IO substance_NN1 use_NN1_VV0 experimentation_NN1 versus_II the_AT progression_NN1 from_II use_NN1 to_II abuse_NN1 and_CC dependence_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  124 We also know that many individuals initiate use and progress to addiction without concept of universal vulnerability ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  124 We_PPIS2 also_RR know_VV0 that_CST many_DA2 individuals_NN2 initiate_VV0 use_NN1_VV0 and_CC progress_NN1_VV0@ to_II addiction_NN1 without_IW concept_NN1 of_IO universal_JJ vulnerability_NN1 )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  125 The challenge for the future is to learn much more about this genetic diversity and , most importantly , to learn how it can be made relevant and useful to the tasks of preventing and treating substance abuse .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  125 The_AT challenge_NN1 for_IF the_AT future_NN1 is_VBZ to_TO learn_VVI much_DA1_RR more_DAR_RRR about_II this_DD1 genetic_JJ diversity_NN1 and_CC ,_Y most_RGT importantly_RR ,_Y to_TO learn_VVI how_RRQ it_PPH1 can_VM be_VBI made_VVN relevant_JJ and_CC useful_JJ to_II the_AT tasks_NN2 of_IO preventing_VVG and_CC treating_VVG substance_NN1 abuse_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  126 We have yet to see whether the specific nature of individuals ' genetic vulnerability profile can be used to guide the development or selection of pharmacotherapy , and whether different pharmacotherapies might be specific to or have differential effectiveness in different individuals .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  126 We_PPIS2 have_VH0 yet_RR to_TO see_VVI whether_CSW the_AT specific_JJ nature_NN1 of_IO individuals_NN2 '_GE genetic_JJ vulnerability_NN1 profile_NN1 can_VM be_VBI used_VVN to_TO guide_VVI the_AT development_NN1 or_CC selection_NN1 of_IO pharmacotherapy_NN1 ,_Y and_CC whether_CSW different_JJ pharmacotherapies_NN2 might_VM be_VBI specific_JJ to_II or_CC have_VH0 differential_JJ effectiveness_NN1 in_II different_JJ individuals_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  127 The continuing exploration of genetic risk factors will be most useful if it can move beyond identifying increased risk and begin guiding therapy development and individualized therapy selection .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  127 The_AT continuing_JJ exploration_NN1 of_IO genetic_JJ risk_NN1 factors_NN2 will_VM be_VBI most_RGT useful_JJ if_CS_CSW@ it_PPH1 can_VM move_VVI beyond_II identifying_VVG increased_JJ risk_NN1 and_CC begin_VVI guiding_JJ therapy_NN1 development_NN1 and_CC individualized_JJ@_VVD therapy_NN1 selection_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  128 <p> The developmental aspect of substance use disorders is another problem area for behavioral pharmacology .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  128 <p>_Y The_AT developmental_JJ aspect_NN1 of_IO substance_NN1 use_NN1_VV0 disorders_NN2 is_VBZ another_DD1 problem_NN1 area_NN1 for_IF behavioral_JJ_NN1 pharmacology_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  129 Age-related variables do play a very significant role in the development of drug abuse , yet very few investigators have taken a developmental approach .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  129 Age-related_JJ_NN1 variables_NN2 do_VD0 play_VVI a_AT1 very_RG significant_JJ role_NN1 in_II the_AT development_NN1 of_IO drug_NN1 abuse_NN1 ,_Y yet_RR very_RG few_DA2 investigators_NN2 have_VH0 taken_VVN a_AT1 developmental_JJ approach_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  130 Much of the field is based on studies with adults , especially adult males , although we know that adolescence is a critical period for the development of drug use disorders .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  130 Much_DA1 of_IO the_AT field_NN1 is_VBZ based_VVN on_II studies_NN2 with_IW adults_NN2 ,_Y especially_RR adult_JJ@_NN1 males_NN2 ,_Y although_CS we_PPIS2 know_VV0 that_DD1_CST adolescence_NN1 is_VBZ a_AT1 critical_JJ period_NN1 for_IF the_AT development_NN1 of_IO drug_NN1 use_NN1_VV0 disorders_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  131 More However , these are methodologically challenging in both animals and humans .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  131 More_RGR_RRR However_RR ,_Y these_DD2 are_VBR methodologically_RR challenging_VVG in_RP@_II both_RR animals_NN2 and_CC humans_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  132 In the preclinical laboratories , most of this work is conducted in rodent models where the developmental period of adolescence is very brief , thus allowing only a limited window of opportunity for study .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  132 In_II the_AT preclinical_JJ laboratories_NN2 ,_Y most_DAT of_IO this_DD1 work_NN1 is_VBZ conducted_VVN in_II rodent_NN1 models_NN2 where_RRQ_CS the_AT developmental_JJ period_NN1 of_IO adolescence_NN1 is_VBZ very_RG brief_JJ ,_Y thus_RR allowing_VVG only_RR a_AT1 limited_JJ window_NN1 of_IO opportunity_NN1 for_IF study_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  133 In the clinical field , observational or qualitative studies are more common than interventional studies because research with vulnerable adolescents can raise special ethical and regulatory hurdles .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  133 In_II the_AT clinical_JJ field_NN1 ,_Y observational_JJ or_CC qualitative_JJ studies_NN2 are_VBR more_RGR common_JJ than_CSN interventional_JJ studies_NN2 because_CS research_NN1 with_IW vulnerable_JJ adolescents_NN2 can_VM raise_VVI special_JJ ethical_JJ and_CC regulatory_JJ hurdles_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  134 <p> In two areas , expansion of the methodological approach in behavioral pharmacology may be challenging , but potentially fruitful .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  134 <p>_Y In_II two_MC areas_NN2 ,_Y expansion_NN1 of_IO the_AT methodological_JJ approach_NN1 in_II behavioral_JJ_NN1 pharmacology_NN1 may_VM be_VBI challenging_JJ_VVG ,_Y but_CCB potentially_RR fruitful_JJ ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  135 The first is the application of multivariate approaches .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  135 The_AT first_MD is_VBZ the_AT application_NN1 of_IO multivariate_JJ approaches_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  136 Behavioral pharmacology comes : from a strong tradition in both behavioral sciences and pharmacology of single variable manipulations in highly controlled settings .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  136 Behavioral_JJ_NN1 pharmacology_NN1 comes_VVZ :_Y from_II a_AT1 strong_JJ tradition_NN1 in_II both_DB2_RR behavioral_JJ sciences_NN2 and_CC pharmacology_NN1 of_IO single_JJ variable_NN1_JJ manipulations_NN2 in_II_RP@ highly_RR controlled_VVN_VVD_JJ@ settings_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  137 This bears little resemblances to real life .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  137 This_DD1 bears_VVZ little_JJ resemblances_NN2 to_II real_JJ life_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  138 Behavioral pharmacologists use experimental designs and often use univariate statistical procedures that have been in existence for over 50 years and have not fully incorporated important developments in multivariate methods and longitudinal research ( Collins Sayer , 2001 ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  138 Behavioral_JJ_NN1 pharmacologists_NN2 use_VV0 experimental_JJ designs_NN2 and_CC often_RR use_VV0 univariate_VV0_NN1 statistical_JJ procedures_NN2 that_CST have_VH0 been_VBN in_II existence_NN1 for_IF over_RG 50_MC years_NNT2 and_CC have_VH0 not_XX fully_RR incorporated_VVN important_JJ developments_NN2 in_II multivariate_JJ methods_NN2 and_CC longitudinal_JJ research_NN1 (_Y Collins_NP1 Sayer_NP1 ,_Y 2001_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  139 The second methodological challenge arises from the emergence of the field of molecular biology Koob Le Moal , 2006 ; Madras et al. , 2006 ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  139 The_AT second_MD methodological_JJ challenge_NN1 arises_VVZ from_II the_AT emergence_NN1 of_IO the_AT field_NN1 of_IO molecular_JJ biology_NN1 Koob_NP1 Le_NP1 Moal_NP1 ,_Y 2006_MC ;_Y Madras_NP1 et_RA21 al._RA22 ,_Y 2006_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  140 While some very useful multidisciplinary work has been done in this area , some new approaches are probably needed .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  140 While_CS some_DD very_RG useful_JJ multidisciplinary_JJ_NN1 work_NN1 has_VHZ been_VBN done_VDN in_II this_DD1 area_NN1 ,_Y some_DD new_JJ approaches_NN2 are_VBR probably_RR needed_VVN_VVD ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  141 For example , behavioral pharmacology traditionally uses within-subject designs , whereas genetically-altered animals typically require group designs .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  141 For_REX21 example_REX22 ,_Y behavioral_JJ_NN1 pharmacology_NN1 traditionally_RR uses_VVZ within-subject_NN1_JJ@ designs_NN2 ,_Y whereas_CS genetically-altered_JJ animals_NN2 typically_RR require_VV0 group_NN1 designs_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  142 <p> An area of opportunity for future research is the question of the extent of pharmacological specificity of various procedures , mechanisms , and interventions across different forms of substance abuse .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  142 <p>_Y An_AT1 area_NN1 of_IO opportunity_NN1 for_IF future_JJ_NN1 research_NN1 is_VBZ the_AT question_NN1 of_IO the_AT extent_NN1 of_IO pharmacological_JJ specificity_NN1 of_IO various_JJ procedures_NN2 ,_Y mechanisms_NN2 ,_Y and_CC interventions_NN2 across_II different_JJ forms_NN2 of_IO substance_NN1 abuse_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  143 From the pharmacological perspective , we tend to think of different types of substance abuse as being very distinct and involving quite different neuropharmacological mechanisms , and we tend to expect that pharmacotherapies will likely have a fairly narrow pharmacological specificity for a particular type of substance abuse .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  143 From_II the_AT pharmacological_JJ perspective_NN1 ,_Y we_PPIS2 tend_VV0 to_TO think_VVI of_IO different_JJ types_NN2 of_IO substance_NN1 abuse_NN1 as_CSA being_VBG very_RG distinct_JJ and_CC involving_VVG quite_RG different_JJ neuropharmacological_JJ mechanisms_NN2 ,_Y and_CC we_PPIS2 tend_VV0 to_TO expect_VVI that_CST pharmacotherapies_NN2 will_VM likely_RR@ have_VHI a_AT1 fairly_RR narrow_JJ pharmacological_JJ specificity_NN1 for_IF a_AT1 particular_JJ type_NN1 of_IO substance_NN1 abuse_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  144 However , to the extent that different varieties of substance abuse may involve common , nonspecific vulnerability factors , or may involve common neurocognitive or affective elements , or , finally , may share final common pathways , we may discover nonspecific pharmacological treatments with efficacy across pharmacologically different forms of substance abuse .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  144 However_RR ,_Y to_II the_AT extent_NN1 that_CST_DD1 different_JJ varieties_NN2 of_IO substance_NN1 abuse_NN1 may_VM involve_VVI common_JJ ,_Y nonspecific_JJ vulnerability_NN1 factors_NN2 ,_Y or_CC may_VM involve_VVI common_JJ neurocognitive_JJ or_CC affective_JJ elements_NN2 ,_Y or_CC ,_Y finally_RR ,_Y may_VM share_VVI final_JJ common_JJ pathways_NN2 ,_Y we_PPIS2 may_VM discover_VVI nonspecific_JJ pharmacological_JJ treatments_NN2 with_IW efficacy_NN1 across_II_RL@ pharmacologically_RR different_JJ forms_NN2 of_IO substance_NN1 abuse_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  145 Learning more about the great impact in the future .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  145 Learning_VVG_NN1 more_RRR_DAR about_II the_AT great_JJ impact_NN1 in_II the_AT future_NN1_JJ ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  146 <p> L : AUTHOR REFLECTIONS ROBERT BALSTER <p> I was fortunate to be among the second to third generation of behavioral pharmacologists .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  146 <p>_Y L_ZZ1_NP1@ :_Y AUTHOR_NN1 REFLECTIONS_NN2 ROBERT_NP1 BALSTER_NN1 <p>_Y I_PPIS1 was_VBDZ fortunate_JJ to_TO be_VBI among_II the_AT second_NNT1_MD to_II third_MD generation_NN1 of_IO behavioral_JJ_NN1 pharmacologists_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  147 I did my graduate work in the behavioral pharmacology laboratories of Robert T. Harris , obtaining my Ph.D .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  147 I_PPIS1 did_VDD my_APPGE graduate_NN1 work_VVI in_II the_AT behavioral_JJ_NN1 pharmacology_NN1 laboratories_NN2 of_IO Robert_NP1 T._NP1 Harris_NP1 ,_Y obtaining_VVG my_APPGE Ph.D_NP1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  148 in Psychology from the University of Houston .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  148 in_II Psychology_NN1 from_II the_AT University_NN1 of_IO Houston_NP1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  149 My graduate work was on drug discrimination where Bob Harris and I demonstrated that amphetamine could lower rates of behavior if animals were trained to respond slowly in its presence and rapidly with placebo ( Harris Balster , 1968 ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  149 My_APPGE graduate_NN1 work_NN1 was_VBDZ on_II drug_NN1 discrimination_NN1 where_CS_RRQ Bob_NP1 Harris_NP1 and_CC I_PPIS1 demonstrated_VVD that_DD1_CST amphetamine_NN1_VV0 could_VM lower_VVI rates_NN2 of_IO behavior_NN1 if_CS animals_NN2 were_VBDR trained_VVN to_TO respond_VVI slowly_RR in_II its_Z' presence_NN1 and_CC rapidly_RR with_IW placebo_NN1 (_Y Harris_NP1 Balster_NP1 ,_Y 1968_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  150 The work I did with Bob Harris is included in Pickens and Thompson ( 1970 ) <p> STIMULUS PROPERTIES OF DRUGS .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  150 The_AT work_NN1 I_PPIS1 did_VDD with_IW Bob_NP1 Harris_NP1 is_VBZ included_VVN in_II Pickens_NP1_NN2 and_CC Thompson_NP1 (_Y 1970_MC )_Y <p>_Y STIMULUS_NPX PROPERTIES_NN2 OF_IO DRUGS_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  151 <p> In 1970 , I went on to the laboratories of Charles R. Schuster to do a postdoctoral fellowship .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  151 <p>_Y In_II 1970_MC ,_Y I_PPIS1 went_VVD on_RP_II21 to_II_II22 the_AT laboratories_NN2 of_IO Charles_NP1 R._NP1 Schuster_NP1_NN1 to_TO do_VDI a_AT1 postdoctoral_JJ_NN1 fellowship_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  152 Other trainees there at the time included Chris-Ellyn Johanson , Marian Fischman , Linda Dykstra , and Klaus Miczek , all of whom emerged as important leaders in behavioral pharmacology research .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  152 Other_JJ trainees_NN2 there_RL at_II the_AT time_NNT1 included_VVD_VVN Chris-Ellyn_NP1 Johanson_NP1 ,_Y Marian_NP1 Fischman_NP1 ,_Y Linda_NP1 Dykstra_NP1 ,_Y and_CC Klaus_NP1 Miczek_NP1 ,_Y all_DB of_IO whom_PNQO emerged_VVD as_RG@_CSA important_JJ leaders_NN2 in_II behavioral_JJ_NN1 pharmacology_NN1 research_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  153 While working with Dr. Schuster , I published several studies of drug self-administration using rhesus monkeys .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  153 While_CS working_VVG with_IW Dr._NNB Schuster_NP1 ,_Y I_PPIS1 published_VVD several_DA2 studies_NN2 of_IO drug_NN1 self-administration_NN1 using_VVG rhesus_NN1 monkeys_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  154 It was solidified , fostered by meetings of the Committee on Problems of Drug Dependence ( CPDD ) and the Division of Psychopharmacology of the American Psychological Association .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  154 It_PPH1 was_VBDZ solidified_VVD ,_Y fostered_VVN by_II meetings_NN2 of_IO the_AT Committee_NN1 on_II Problems_NN2 of_IO Drug_NN1 Dependence_NN1 (_Y CPDD_NP1 )_Y and_CC the_AT Division_NN1 of_IO Psychopharmacology_NN1 of_IO the_AT American_JJ Psychological_JJ Association_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  155 Another important organization of behavioral pharmacologists working in the area of drug abuse is the International Study Group Investigating Drugs as Reinforcers ( ISGIDAR ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  155 Another_DD1 important_JJ organization_NN1 of_IO behavioral_JJ_NN1 pharmacologists_NN2 working_VVG in_II the_AT area_NN1 of_IO drug_NN1 abuse_NN1 is_VBZ the_AT International_JJ Study_NN1 Group_NN1 Investigating_VVG Drugs_NN2 as_CSA_II@ Reinforcers_NP1_NN2 (_Y ISGIDAR_NP1 )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  156 Of particular importance to me as a young scientist was that Dr. Schuster enlisted Chris-Ellyn Johanson and me to organize a multi-laboratory validation effort for ISGIDAR , which resulted in one of the first extensive comparisons of animal and human data on abuse potential ( Johanson Balster , 1978 ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  156 Of_IO particular_JJ importance_NN1 to_II me_PPIO1 as_II a_AT1 young_JJ scientist_NN1 was_VBDZ that_CST Dr._NNB Schuster_NP1 enlisted_VVD Chris-Ellyn_NP1 Johanson_NP1 and_CC me_PPIO1 to_TO organize_VVI a_AT1 multi-laboratory_JJ_NN1 validation_NN1 effort_NN1 for_IF ISGIDAR_NP1_NN1 ,_Y which_DDQ resulted_VVD in_II one_MC1 of_IO the_AT first_MD extensive_JJ comparisons_NN2 of_IO animal_NN1 and_CC human_JJ data_NN on_II abuse_NN1 potential_NN1 (_Y Johanson_NP1 Balster_NP1 ,_Y 1978_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  157 These were heady times for behavioral pharmacology as learning theories of addiction were forming and expanding .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  157 These_DD2 were_VBDR heady_JJ times_NNT2 for_IF behavioral_JJ_NN1 pharmacology_NN1 as_CSA_II@ learning_VVG_NN1 theories_NN2 of_IO addiction_NN1 were_VBDR forming_VVG and_CC expanding_JJ_VVG ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  158 <p> After a one-year faculty position at Duke , Louis Harris recruited me to join his Department of Pharmacology and Toxicology at the Medical College of Virginia ( MCV ) , where I have stayed ever since .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  158 <p>_Y After_CS_II a_AT1 one-year_JJ faculty_NN1 position_NN1 at_II Duke_NN1 ,_Y Louis_NP1 Harris_NP1 recruited_VVD@ me_PPIO1 to_TO join_VVI his_APPGE Department_NN1 of_IO Pharmacology_NP1_NN1 and_CC Toxicology_NN1_NP1 at_II the_AT Medical_JJ College_NN1 of_IO Virginia_NP1 (_Y MCV_MC )_Y ,_Y where_CS_RRQ I_PPIS1 have_VH0 stayed_VVN ever_RR since_RR@ ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  159 At this point , my work took a decidedly more pharmacological direction , but I continued to use the approaches and methods of behavioral pharmacology throughout my career .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  159 At_II this_DD1 point_NN1 ,_Y my_APPGE work_NN1 took_VVD a_AT1 decidedly_RR more_RGR pharmacological_JJ direction_NN1 ,_Y but_CCB I_PPIS1 continued_VVD to_TO use_VVI the_AT approaches_NN2 and_CC methods_NN2 of_IO behavioral_JJ_NN1 pharmacology_NN1 throughout_II my_APPGE career_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  160 MCV has in the pharmacology of drugs of abuse and has a strong core of behavioral pharmacologists , some of whom were my trainees .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  160 MCV_MC has_VHZ in_II the_AT pharmacology_NN1 of_IO drugs_NN2 of_IO abuse_NN1 and_CC has_VHZ a_AT1 strong_JJ core_NN1 of_IO behavioral_JJ_NN1 pharmacologists_NN2 ,_Y some_DD of_IO whom_PNQO were_VBDR my_APPGE trainees_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  161 My primary areas of research have been with phencyclidine-like drugs , abused inhalants , and abuse potential assessment , but including cannabinoids , stimulants , and opioids as well .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  161 My_APPGE primary_JJ_NN1 areas_NN2 of_IO research_NN1 have_VH0 been_VBN with_IW phencyclidine-like_JJ drugs_NN2 ,_Y abused_JJ@_VVN_VVD@ inhalants_NN2 ,_Y and_CC abuse_VV0@_NN1 potential_JJ_NN1 assessment_NN1 ,_Y but_CCB including_II cannabinoids_NN2 ,_Y stimulants_NN2 ,_Y and_CC opioids_NN2 as_RR21_RG well_RR22_RR ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  162 I was also fortunate to work with a strong group of graduate students and post-doctoral fellows supported by a National Institute on Drug Abuse ( NIDA ) training grant and individual fellowships .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  162 I_PPIS1 was_VBDZ also_RR fortunate_JJ to_TO@ work_VVI with_IW a_AT1 strong_JJ group_NN1 of_IO graduate_NN1 students_NN2 and_CC post-doctoral_JJ fellows_NN2 supported_VVN by_II a_AT1 National_JJ Institute_NN1 on_II Drug_NN1 Abuse_NN1 (_Y NIDA_NP1 )_Y training_NN1_VVG@ grant_NN1 and_CC individual_JJ fellowships_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  163 I have also been fortunate to be involved in international collaborations and training experiences .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  163 I_PPIS1 have_VH0 also_RR been_VBN fortunate_JJ to_TO be_VBI involved_JJ in_II international_JJ collaborations_NN2 and_CC training_NN1_VVG@ experiences_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  164 <p> SHARON WALSH <p> I began my graduate training in the newly emerging field of behavioral neuroscience in 1985 at Rutgers University in New Jersey .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  164 <p>_Y SHARON_NP1 WALSH_NP1 <p>_Y I_PPIS1 began_VVD my_APPGE graduate_NN1 training_NN1_VVG@ in_II the_AT newly_RR emerging_JJ_VVG field_NN1 of_IO behavioral_JJ_NN1 neuroscience_NN1 in_II 1985_MC at_II Rutgers_NP1 University_NN1 in_II New_NP1 Jersey_NP1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  165 My academic home was in the Department of Psychology , a department with a reputation for its strength in the study and application of classical and operant learning theory .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  165 My_APPGE academic_JJ home_NN1 was_VBDZ in_II the_AT Department_NN1 of_IO Psychology_NN1 ,_Y a_AT1 department_NN1 with_IW a_AT1 reputation_NN1 for_IF its_Z' strength_NN1 in_II the_AT study_NN1 and_CC application_NN1 of_IO classical_JJ and_CC operant_JJ_NN1 learning_NN1 theory_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  166 Notable faculty included John Falk , Michael D'Amato , Charlie Flaherty , and George Collier .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  166 Notable_JJ faculty_NN1 included_VVD John_NP1 Falk_NP1 ,_Y Michael_NP1 D'Amato_NP1 ,_Y Charlie_NP1 Flaherty_NP1 ,_Y and_CC George_NP1 Collier_NP1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  167 However , as a young student with interests in neuroscience and neuropharmacology , my training extended into affiliated and the Robert Wood Johnson Medical School .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  167 However_RR ,_Y as_CSA_II a_AT1 young_JJ student_NN1 with_IW interests_NN2 in_II neuroscience_NN1 and_CC neuropharmacology_NN1 ,_Y my_APPGE training_NN1 extended_VVN_VVD into_II affiliated_JJ and_CC the_AT Robert_NP1 Wood_NP1 Johnson_NP1 Medical_JJ School_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  168 My primary mentor , George Wagner , trained with Lew Selden , the notable behavioral neuropharmacologist at the University of Chicago .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  168 My_APPGE primary_JJ_NN1 mentor_NN1 ,_Y George_NP1 Wagner_NP1 ,_Y trained_VVN with_IW Lew_NP1 Selden_NP1 ,_Y the_AT notable_JJ behavioral_JJ_NN1 neuropharmacologist_NN1 at_II the_AT University_NN1 of_IO Chicago_NP1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  169 Our laboratory focused primarily on the evaluation of neurotoxic agents on behavior and neurochemical outcomes , a new discipline merging the principles of behavioral pharmacology and neuropharmacology into behavioral toxicology .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  169 Our_APPGE laboratory_NN1 focused_VVD_VVN primarily_RR on_II the_AT evaluation_NN1 of_IO neurotoxic_JJ agents_NN2 on_II behavior_NN1 and_CC neurochemical_JJ outcomes_NN2 ,_Y a_AT1 new_JJ discipline_NN1 merging_VVG the_AT principles_NN2 of_IO behavioral_JJ_NN1 pharmacology_NN1 and_CC neuropharmacology_NN1 into_II behavioral_JJ_NN1 toxicology_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  170 <p> I was fortunate to complete fellowship training at perhaps the most successful training program in human behavioral pharmacology , the Behavioral Pharmacology Research Unit at Johns Hopkins University .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  170 <p>_Y I_PPIS1 was_VBDZ fortunate_JJ to_TO complete_VVI fellowship_NN1 training_NN1_VVG@ at_II perhaps_RR the_AT most_RGT successful_JJ training_NN1 program_NN1 in_II human_JJ_NN1 behavioral_JJ_NN1 pharmacology_NN1 ,_Y the_AT Behavioral_JJ_NP1_NN1 Pharmacology_NN1_NP1 Research_NN1 Unit_NN1 at_II Johns_NP1 Hopkins_NP1 University_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  171 My mentors included Kenzie Preston , George Bigelow , and Maxine Stitzer .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  171 My_APPGE mentors_NN2 included_VVD_VVN Kenzie_NP1 Preston_NP1 ,_Y George_NP1 Bigelow_NP1 ,_Y and_CC Maxine_NP1 Stitzer_NP1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  172 I arrived at an exciting time of expansion and immediately began working on basic human laboratory studies of an emerging medication for opioid dependence , buprenorphine .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  172 I_PPIS1 arrived_VVD at_II an_AT1 exciting_JJ time_NNT1 of_IO expansion_NN1 and_CC immediately_RR began_VVD working_VVG on_II_RP@ basic_JJ human_JJ_NN1 laboratory_NN1 studies_NN2 of_IO an_AT1 emerging_JJ medication_NN1 for_IF opioid_JJ_NN1 dependence_NN1 ,_Y buprenorphine_VV0_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  173 After completing a two-year fellowship , I was offered a faculty position as an Assistant Professor and remained at Johns Hopkins for another 13 years .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  173 After_II completing_VVG a_AT1 two-year_JJ fellowship_NN1 ,_Y I_PPIS1 was_VBDZ offered_VVN a_AT1 faculty_NN1 position_NN1 as_II_CSA an_AT1 Assistant_JJ_NN1 Professor_NN1 and_CC remained_VVD_VVN at_II Johns_NP1 Hopkins_NP1 for_IF another_DD1 13_MC years_NNT2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  174 Throughout that time , my work expanded to incorporate the development of medications in cocaine and opioid dependence , development of self-administration procedures incorporating alternative reinforcers , and pharmacodynamic and pharmacokinetic studies of drugs first presentation of human research to the CPDD in 1991 and found a scientific home among peers and supportive ( and sometimes challenging ) senior investigators , including Marian Fischman , Mary Jeanne Kreek , and Jim Woods .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  174 Throughout_II that_DD1 time_NNT1 ,_Y my_APPGE work_NN1 expanded_VVD_VVN to_TO incorporate_VVI the_AT development_NN1 of_IO medications_NN2 in_II cocaine_NN1 and_CC opioid_JJ_NN1 dependence_NN1 ,_Y development_NN1 of_IO self-administration_JJ_NN1 procedures_NN2 incorporating_VVG alternative_JJ_NN1 reinforcers_NN2 ,_Y and_CC pharmacodynamic_JJ and_CC pharmacokinetic_JJ studies_NN2 of_IO drugs_NN2 first_MD presentation_NN1 of_IO human_JJ_NN1 research_NN1 to_II the_AT CPDD_NP1 in_II 1991_MC and_CC found_VVD_VVN a_AT1 scientific_JJ home_NN1 among_II peers_NN2 and_CC supportive_JJ (_Y and_CC sometimes_RT challenging_VVG_JJ )_Y senior_JJ investigators_NN2 ,_Y including_II Marian_NP1 Fischman_NP1 ,_Y Mary_NP1 Jeanne_NP1 Kreek_NP1 ,_Y and_CC Jim_NP1 Woods_NP1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  175 1 left Johns Hopkins in 2005 for a new opportunity at the University of Kentucky in Lexington , an environment steeped in the history of substance abuse research owing to the pioneering work conducted at the Lexington Narcotics Prison Farm .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  175 1_MC1 left_JJ_VVD Johns_NP1 Hopkins_NP1 in_II 2005_MC for_IF a_AT1 new_JJ opportunity_NN1 at_II the_AT University_NN1 of_IO Kentucky_NP1 in_II Lexington_NP1 ,_Y an_AT1 environment_NN1 steeped_VVN in_II the_AT history_NN1 of_IO substance_NN1 abuse_NN1 research_NN1 owing_II21 to_II22 the_AT pioneering_JJ work_NN1 conducted_VVN_VVD at_II the_AT Lexington_NP1_NN1@ Narcotics_NN2 Prison_NN1 Farm_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  176 I have been very fortunate to work closely with so many creative and thoughtful behavior pharmacologists and to find a small niche that allowed me to integrate my early neuropharmacology training into human behavioral pharmacology .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  176 I_PPIS1 have_VH0 been_VBN very_RG fortunate_JJ to_TO@ work_VVI closely_RR with_IW so_RG many_DA2 creative_JJ and_CC thoughtful_JJ behavior_NN1 pharmacologists_NN2 and_CC to_TO find_VVI a_AT1 small_JJ niche_NN1 that_CST allowed_VVD me_PPIO1 to_TO integrate_VVI my_APPGE early_JJ neuropharmacology_NN1 training_NN1_VVG@ into_II human_JJ_NN1 behavioral_JJ_NN1 pharmacology_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  177 <p> GEORGE BIGELOW <p> I was introduced to the operant behavioral perspective in the 1960s as a psychology undergraduate at the University of Maryland where several prominent operant conditioners were on the faculty--such as Joseph V. Brady , Lewis Gollub , and Jack Findley--and I received practical primate behavioral laboratory experience as a research assistant to Charles Ferster at the Institute for Behavioral Research .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  177 <p>_Y GEORGE_NP1 BIGELOW_NP1_NN1 <p>_Y I_PPIS1 was_VBDZ introduced_VVN to_II the_AT operant_JJ_NN1 behavioral_JJ_NN1 perspective_NN1 in_II the_AT 1960s_MC2 as_II_CSA a_AT1 psychology_NN1 undergraduate_NN1 at_II the_AT University_NN1 of_IO Maryland_NP1 where_CS_RRQ several_DA2 prominent_JJ operant_JJ_NN1 conditioners_NN2 were_VBDR on_II the_AT faculty--such_DA as_CSA Joseph_NP1 V._II Brady_NP1 ,_Y Lewis_NP1 Gollub_NP1 ,_Y and_CC Jack_NP1 Findley--and_NP1 I_PPIS1 received_VVD practical_JJ primate_NN1 behavioral_NN1_JJ laboratory_NN1 experience_NN1_VV0 as_II_CSA a_AT1 research_NN1 assistant_NN1 to_II Charles_NP1 Ferster_NP1_NN1 at_II the_AT Institute_NN1 for_IF Behavioral_JJ_NN1_NP1 Research_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  178 This background and experience were instrumental in helping me arrange to graduate school at the University of Minnesota , where Thompson directed the training program in psychopharmacology .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  178 This_DD1 background_NN1 and_CC experience_NN1 were_VBDR instrumental_JJ in_II helping_VVG me_PPIO1 arrange_VVI to_TO graduate_VVI school_NN1 at_II the_AT University_NN1 of_IO Minnesota_NP1 ,_Y where_CS_RRQ Thompson_NP1 directed_VVD the_AT training_NN1 program_NN1 in_II psychopharmacology_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  179 Thompson and C.R. Schuster had just recently done the first studies of opioid drug self-administration in primates and were working on their classic textbook , Behavioral Pharmacology .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  179 Thompson_NP1 and_CC C.R._NP1 Schuster_NP1 had_VHD just_RR recently_RR done_VDN the_AT first_MD studies_NN2 of_IO opioid_JJ_NN1 drug_NN1 self-administration_NN1 in_II primates_NN2 and_CC were_VBDR working_VVG on_II_RP@ their_APPGE classic_JJ_NN1 textbook_NN1 ,_Y Behavioral_NP1_JJ Pharmacology_NP1_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  180 It was a wonderful training environment , with excellent opportunities and faculty and an outstanding group of graduate students , many of whom have gone on to make substantial contributions in behavioral pharmacology .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  180 It_PPH1 was_VBDZ a_AT1 wonderful_JJ training_NN1 environment_NN1 ,_Y with_IW excellent_JJ opportunities_NN2 and_CC faculty_NN1 and_CC an_AT1 outstanding_JJ group_NN1 of_IO graduate_NN1 students_NN2 ,_Y many_DA2 of_IO whom_PNQO have_VH0 gone_VVN on_RP to_TO make_VVI substantial_JJ contributions_NN2 in_II behavioral_JJ_NN1 pharmacology_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  181 It was here !
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  181 It_PPH1 was_VBDZ here_RL !_Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  182 began studying drug-behavior interactions , and I stayed on for postdoctoral training in behavioral pharmacology , working with Roy Pickens , beginning a decades-long collaboration with Roland Griffiths , and beginning to extend my work and interests to human research .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  182 began_VVD studying_VVG drug-behavior_JJ_NN1 interactions_NN2 ,_Y and_CC I_PPIS1 stayed_VVD on_RP@ for_IF postdoctoral_JJ_NN1 training_NN1 in_II behavioral_JJ_NN1 pharmacology_NN1 ,_Y working_VVG with_IW Roy_NP1 Pickens_NP1 ,_Y beginning_VVG a_AT1 decades-long_JJ collaboration_NN1 with_IW Roland_NP1 Griffiths_NP1 ,_Y and_CC beginning_VVG_NN1 to_TO extend_VVI my_APPGE work_NN1 and_CC interests_NN2 to_II human_JJ_NN1 research_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  183 Subsequently , I have only had one job : I was recruited by Joe Brady and Lou Faillace in 1971 to my current position at Johns Hopkins , focusing primarily on human behavioral pharmacology research related to substance abuse .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  183 Subsequently_RR ,_Y I_PPIS1 have_VH0 only_RR had_VHN one_MC1 job_NN1 :_Y I_PPIS1 was_VBDZ recruited_VVN by_II Joe_NP1 Brady_NP1 and_CC Lou_NP1 Faillace_NP1 in_II 1971_MC to_II my_APPGE current_JJ position_NN1 at_II Johns_NP1 Hopkins_NP1 ,_Y focusing_VVG primarily_RR on_II human_JJ_NN1 behavioral_JJ_NN1 pharmacology_NN1 research_NN1 related_VVN_VVD to_II substance_NN1 abuse_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  184 <p> At Hopkins , we developed a postdoctoral research training program on the human behavioral pharmacology of substance that has now been supported by the National over 25 years .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  184 <p>_Y At_II Hopkins_NP1 ,_Y we_PPIS2 developed_VVD a_AT1 postdoctoral_JJ_NN1 research_NN1 training_NN1 program_NN1 on_II the_AT human_JJ_NN1 behavioral_JJ_NN1 pharmacology_NN1 of_IO substance_NN1 that_CST_DD1 has_VHZ now_RT been_VBN supported_VVN by_II the_AT National_JJ over_RG 25_MC years_NNT2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  185 From the beginning , our core faculty were Roland Griffiths , Maxine Stitizer , Ira Liebson , and me .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  185 From_II the_AT beginning_NN1 ,_Y our_APPGE core_NN1 faculty_NN1 were_VBDR Roland_NP1 Griffiths_NP1 ,_Y Maxine_NP1 Stitizer_NP1 ,_Y Ira_NP1 Liebson_NP1 ,_Y and_CC me_PPIO1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  186 Our goal has been to apply rigorous , parametric , behavioral pharmacology methods to human research on drugs of abuse , both in the laboratory and the clinic , to extend these methods to all ( or most ) major classes of abused drugs , and to develop a program of research extending from human laboratory basic science to outpatient applied therapeutics .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  186 Our_APPGE goal_NN1 has_VHZ been_VBN to_TO apply_VVI rigorous_JJ ,_Y parametric_JJ ,_Y behavioral_JJ_NN1 pharmacology_NN1 methods_NN2 to_II human_JJ_NN1 research_NN1 on_II drugs_NN2 of_IO abuse_NN1 ,_Y both_RR_DB2 in_II the_AT laboratory_NN1 and_CC the_AT clinic_NN1 ,_Y to_TO extend_VVI these_DD2 methods_NN2 to_II_TO all_RR@ (_Y or_CC most_DAT_RGT )_Y major_JJ classes_NN2 of_IO abused_JJ@ drugs_NN2 ,_Y and_CC to_TO develop_VVI a_AT1 program_NN1 of_IO research_NN1 extending_VVG from_II human_JJ_NN1 laboratory_NN1 basic_JJ science_NN1 to_II outpatient_NN1 applied_JJ_VVD_VVN therapeutics_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  187 Major themes or methodologies have included drug self-administration , drug discrimination , abuse liability assessment , evaluation of performance effects , medications development for substance abuse treatment , contingency management treatment , and **26;5716;TOOLONG integration .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  187 Major_JJ_NP1 themes_NN2 or_CC methodologies_NN2 have_VH0 included_VVN drug_NN1 self-administration_NN1 ,_Y drug_NN1 discrimination_NN1 ,_Y abuse_NN1_VV0@ liability_NN1 assessment_NN1 ,_Y evaluation_NN1 of_IO performance_NN1 effects_NN2 ,_Y medications_NN2 development_NN1 for_IF substance_NN1 abuse_NN1 treatment_NN1 ,_Y contingency_NN1 management_NN1 treatment_NN1 ,_Y and_CC **26;5716;TOOLONG_JJ integration_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  188 The NIDA training grant has provided a vehicle for working with and collaborating with a wonderful array of young scientists who have continued to expand the frontiers of behavioral pharmacology research and its application to problems of drug abuse , dependence , and treatment .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  188 The_AT NIDA_NN1_NP1 training_NN1 grant_NN1 has_VHZ provided_VVN a_AT1 vehicle_NN1 for_IF working_VVG with_IW and_CC collaborating_VVG with_IW a_AT1 wonderful_JJ array_NN1 of_IO young_JJ scientists_NN2 who_PNQS have_VH0 continued_VVN to_TO expand_VVI the_AT frontiers_NN2 of_IO behavioral_JJ_NN1 pharmacology_NN1 research_NN1 and_CC its_Z' application_NN1 to_II problems_NN2 of_IO drug_NN1 abuse_NN1 ,_Y dependence_NN1 ,_Y and_CC treatment_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  189 Some of these training program graduates have stayed on and contributed to our faculty enrichment at Hopkins , whereas others have developed similar me that training programs developed by graduates of our program are now sending us their graduates to be new members of our faculty team .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  189 Some_DD of_IO these_DD2 training_NN1_VVG@ program_NN1 graduates_NN2 have_VH0 stayed_VVN on_RP@_II and_CC contributed_VVN_VVD to_II our_APPGE faculty_NN1 enrichment_NN1 at_II Hopkins_NP1 ,_Y whereas_CS others_NN2 have_VH0 developed_VVN similar_JJ me_PPIO1 that_DD1_CST training_NN1 programs_NN2 developed_VVN by_II graduates_NN2 of_IO our_APPGE program_NN1 are_VBR now_RT sending_VVG us_PPIO2 their_APPGE graduates_NN2 to_TO be_VBI new_JJ members_NN2 of_IO our_APPGE faculty_NN1 team_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  190 <p> L : ACKNOWLEDGEMENTS This paper is based on presentations at a May 2006 conference in Key Largo , Florida entitled Reflections on 40 Years of Drug Abuse Research .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  190 <p>_Y L_ZZ1_NP1@ :_Y ACKNOWLEDGEMENTS_NN2 This_DD1 paper_NN1 is_VBZ based_VVN on_II presentations_NN2 at_II a_AT1 May_NPM1 2006_MC conference_NN1 in_II Key_NP1 Largo_NP1 ,_Y Florida_NP1 entitled_VVN_VVD% Reflections_NN2 on_II 40_MC Years_NNT2 of_IO Drug_NN1 Abuse_NN1 Research_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  191 The authors acknowledge , with thanks , the contribution of James Woods to the behavioral pharmacology presentations at the conference .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  191 The_AT authors_NN2 acknowledge_VV0 ,_Y with_IW thanks_NN2 ,_Y the_AT contribution_NN1 of_IO James_NP1 Woods_NP1 to_II the_AT behavioral_JJ_NN1 pharmacology_NN1 presentations_NN2 at_II the_AT conference_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  192 NIDA grants DA-01442 ( Balster ) , DA016718 DA019433 and DA022191 ( Walsh ) , and DA08045 , DA013034 and DA019497 ( Bigelow ) supported preparation of this manuscript .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  192 NIDA_NP1_NN1 grants_VVZ DA-01442_MC (_Y Balster_NP1 )_Y ,_Y DA016718_FO DA019433_FO and_CC DA022191_FO (_Y Walsh_NP1 )_Y ,_Y and_CC DA08045_FO ,_Y DA013034_FO and_CC DA019497_FO (_Y Bigelow_NP1 )_Y supported_VVD_JJ@ preparation_NN1 of_IO this_DD1 manuscript_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  193 <p> L : REFERENCES -- American Psychiatric Association .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  193 <p>_Y L_ZZ1_NP1@ :_Y REFERENCES_NN2_VVZ@ --_ZZ American_JJ Psychiatric_JJ Association_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  194 2000 Diagnostic and statistical manual of mental disorders .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  194 2000_MC Diagnostic_JJ and_CC statistical_JJ manual_NN1 of_IO mental_JJ disorders_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  195 ( 4th ed .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  195 (_Y 4th_MD ed_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  196 ) , ( DSM IV ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  196 )_Y ,_Y (_Y DSM_NP1 IV_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  197 Washington , DC : American Psychiatric Association .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  197 Washington_NP1 ,_Y DC_NP1 :_Y American_JJ Psychiatric_JJ Association_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  198 <p> -- Anderson , R.L. , Velkey , A.J. , Woolverton , W.R. 2002 The generalized matching law as a predictor of choice between cocaine and food in rhesus monkeys .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  198 <p>_Y --_ZZ Anderson_NP1 ,_Y R.L._NP1 ,_Y Velkey_NP1 ,_Y A.J._NP1 ,_Y Woolverton_NP1 ,_Y W.R._NP1 2002_MC The_AT generalized_JJ matching_JJ_NN1 law_NN1 as_II_CSA a_AT1 predictor_NN1 of_IO choice_NN1 between_II cocaine_NN1 and_CC food_NN1 in_II rhesus_NN1 monkeys_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  199 Psychopharmacology , 163 , 319-326 .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  199 Psychopharmacology_NN1_NP1@ ,_Y 163_MC ,_Y 319-326_MCMC ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  200 <p> -- Balster , R.L. 1991 Drug abuse potential evaluation , 1549-1558 .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  200 <p>_Y --_ZZ Balster_NN1_NP1 ,_Y R.L._NP1 1991_MC Drug_NN1 abuse_NN1 potential_NN1_JJ evaluation_NN1 ,_Y 1549-1558_MCMC ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  201 <p> -- Balster , R.L. , Bigelow , G.E .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  201 <p>_Y --_ZZ Balster_NN1_NP1 ,_Y R.L._NP1 ,_Y Bigelow_NP1_VV0_NN1 ,_Y G.E_NP1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  202 2003 Guidelines and methodological reviews concerning drug abuse liability assessment .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  202 2003_MC Guidelines_NN2 and_CC methodological_JJ reviews_NN2 concerning_II_VVG drug_NN1 abuse_NN1 liability_NN1 assessment_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  203 Drug and Alcohol Dependence , 70 ( Suppl. 3 ) , S13-S40 .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  203 Drug_NN1 and_CC Alcohol_NN1 Dependence_NN1 ,_Y 70_MC (_Y Suppl._NP1 3_MC )_Y ,_Y S13-S40_NN1_JJ ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  204 <p> -- Barrett , J.E .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  204 <p>_Y --_ZZ Barrett_NP1 ,_Y J.E_NP1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  205 2002 The emergence of behavioral pharmacology .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  205 2002_MC The_AT emergence_NN1 of_IO behavioral_JJ_NN1 pharmacology_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  206 Molecular interventions , 2 , 470-475 .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  206 Molecular_JJ interventions_NN2 ,_Y 2_MC ,_Y 470-475_MCMC ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  207 <p> -- Belknap , J.K. , Metten , P. , Beckley , E.H. , Crabbe , J.C .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  207 <p>_Y --_ZZ Belknap_NN1_NP1 ,_Y J.K._NP1 ,_Y Metten_NP1_VV0 ,_Y P._NP1 ,_Y Beckley_NP1 ,_Y E.H._NP1 ,_Y Crabbe_NP1 ,_Y J.C_NP1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  208 2008 Multivariate analyses reveal common and drug-specific genetic influences on responses to four drugs of abuse .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  208 2008_MC Multivariate_JJ analyses_NN2 reveal_VV0 common_JJ and_CC drug-specific_JJ genetic_JJ influences_NN2 on_II responses_NN2 to_II four_MC drugs_NN2 of_IO abuse_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  209 Trends in Pharmacological Sciences , 29 , 547-543 .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  209 Trends_NN2 in_II Pharmacological_JJ_NP1 Sciences_NN2 ,_Y 29_MC ,_Y 547-543_MCMC ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  210 <p> -- Bickel , W.K. , Marsch , L.A. 2001 Toward a behavioral economic understanding of drug dependence : Delay discounting processes .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  210 <p>_Y --_ZZ Bickel_NP1_NN1@ ,_Y W.K._NP1 ,_Y Marsch_NP1_NN1 ,_Y L.A._NP1 2001_MC Toward_II a_AT1 behavioral_JJ economic_JJ understanding_NN1 of_IO drug_NN1 dependence_NN1 :_Y Delay_VV0_NN1 discounting_VVG_NN1 processes_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  211 Addiction , 96 , 73-86 .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  211 Addiction_NPX ,_Y 96_MC ,_Y 73-86_MCMC ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  212 <p> -- Bickel , W.K. , Marsch , L.A. , Carroll , M.E. 2000 Deconstructing relative reinforcing efficacy and situating the measures of pharmacological reinforcement with behavioral economics : A theoretical proposal .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  212 <p>_Y --_ZZ Bickel_NP1_NN1@ ,_Y W.K._NP1 ,_Y Marsch_NP1_NN1 ,_Y L.A._NP1 ,_Y Carroll_NP1 ,_Y M.E._NN1 2000_MC Deconstructing_JJ@_NP1_VVG relative_NN1_JJ reinforcing_VVG_JJ@ efficacy_NN1 and_CC situating_VVG the_AT measures_NN2 of_IO pharmacological_JJ reinforcement_NN1 with_IW behavioral_JJ economics_NN1 :_Y A_ZZ1_AT1@ theoretical_JJ proposal_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  213 Psychophamacology , 153 , 44-56 .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  213 Psychophamacology_NN1_NP1@ ,_Y 153_MC ,_Y 44-56_MCMC ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  214 <p> -- Brady , J.V. , Griffiths , R.R. 1976 Behavioral procedures for evaluating the relative abuse 35 , 2245-2253 .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  214 <p>_Y --_ZZ Brady_NP1 ,_Y J.V._NP1 ,_Y Griffiths_NP1 ,_Y R.R._NP1 1976_MC Behavioral_JJ procedures_NN2 for_IF evaluating_VVG the_AT relative_JJ_NN1 abuse_NN1 35_MC ,_Y 2245-2253_MCMC ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  215 <p> -- Carroll , K.M. , Onken , L.S. 2005 Behavioral therapies for drug abuse .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  215 <p>_Y --_ZZ Carroll_NP1 ,_Y K.M._NNU ,_Y Onken_NP1_NN1 ,_Y L.S._NNU2 2005_MC Behavioral_JJ therapies_NN2 for_IF drug_NN1 abuse_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  216 American Journal of Psychiatry , 162 , 1452-1460 .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  216 American_JJ Journal_NN1 of_IO Psychiatry_NP1_NN1 ,_Y 162_MC ,_Y 1452-1460_MCMC ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  217 <p> -- Chait , L.D. , Uhlenhuth , E.H. , Johanson , C.E. 1984 An experimental paradigm for studying the discriminative stimulus properties of drugs in humans .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  217 <p>_Y --_ZZ Chait_NN1_NP1 ,_Y L.D._NP1 ,_Y Uhlenhuth_NP1_NN1 ,_Y E.H._NP1 ,_Y Johanson_NP1 ,_Y C.E._NP1 1984_MC An_AT1 experimental_JJ paradigm_NN1 for_IF studying_VVG the_AT discriminative_JJ stimulus_NN1 properties_NN2 of_IO drugs_NN2 in_II humans_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  218 Psychopharmacology , 82 , 272-274 .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  218 Psychopharmacology_NN1_NP1@ ,_Y 82_MC ,_Y 272-274_MCMC ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  219 <p> -- Collins , L.M. , Sayer , A.G. ( Eds. ) 2001 New methods for the analysis of change .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  219 <p>_Y --_ZZ Collins_NP1 ,_Y L.M._NP1 ,_Y Sayer_NP1_NN1 ,_Y A.G._FO (_Y Eds._NN2 )_Y 2001_MC New_JJ methods_NN2 for_IF the_AT analysis_NN1 of_IO change_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  220 Washington , DC : American Psychological Association .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  220 Washington_NP1 ,_Y DC_NP1 :_Y American_JJ Psychological_JJ Association_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  221 <p> -- Dole , V.P. , Nyswander , M. 1965 A medical treatment for diacetylmorphine ( heroin ) addiction , a clinical trial with methadone hydrochloride .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  221 <p>_Y --_ZZ Dole_NP1_NN1@ ,_Y V.P._NP1 ,_Y Nyswander_NP1_VV0_NN1 ,_Y M._NN1 1965_MC A_ZZ1_AT1@ medical_JJ treatment_NN1 for_IF diacetylmorphine_NN1 (_Y heroin_NN1 )_Y addiction_NN1 ,_Y a_AT1 clinical_JJ trial_NN1 with_IW methadone_NN1 hydrochloride_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  222 Journal of the American Medical Association , 193 , 646-650 .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  222 Journal_NN1 of_IO the_AT American_JJ Medical_JJ Association_NN1 ,_Y 193_MC ,_Y 646-650_MCMC ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  223 <p> -- Deneau , G.A. , Yanagita , T. , Seevers , M.H. 1969 Self-administration of psychoactive substances by the monkey--A measure of psychological dependence .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  223 <p>_Y --_ZZ Deneau_NN1_NP1 ,_Y G.A._NP1 ,_Y Yanagita_NP1 ,_Y T._NP1 ,_Y Seevers_NP1_VVZ ,_Y M.H._NP1 1969_MC Self-administration_NN1_JJ of_IO psychoactive_JJ substances_NN2 by_II the_AT monkey--A_NN1 measure_NN1 of_IO psychological_JJ dependence_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  224 Psychopharmacologia , 16 , 30-48 .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  224 Psychopharmacologia_NN1_NP1@ ,_Y 16_MC ,_Y 30-48_MCMC ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  225 <p> -- Fischman , M.W. , Mello , N.K. ( Eds. ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  225 <p>_Y --_ZZ Fischman_NN1_NP1 ,_Y M.W._NNU ,_Y Mello_NP1 ,_Y N.K._NP1 (_Y Eds._NN2 )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  226 1989 Testing for abuse liability of drugs in humans .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  226 1989_MC Testing_NN1_VVG_NP1 for_IF abuse_NN1 liability_NN1 of_IO drugs_NN2 in_II humans_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  227 DHHS , Pub .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  227 DHHS_NP1 ,_Y Pub_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  228 No .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  228 No_XX ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  229 ( ADM ) 89-I 613 .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  229 (_Y ADM_NP1 )_Y 89-I_MC 613_MC ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  230 Rockville , MD : Alcohol , Drug Abuse , and Mental Health Administration .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  230 Rockville_NP1 ,_Y MD_NNA :_Y Alcohol_NN1 ,_Y Drug_NN1 Abuse_NN1 ,_Y and_CC Mental_JJ Health_NN1 Administration_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  231 <p> -- Fischman , M.W. , Schuster , C.R. 1982 Cocaine self-administration in humans .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  231 <p>_Y --_ZZ Fischman_NN1_NP1 ,_Y M.W._NNU ,_Y Schuster_NP1_NN1 ,_Y C.R._NP1 1982_MC Cocaine_NN1 self-administration_NN1 in_II humans_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  232 Federation Proceedings , 41 , 241-246 .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  232 Federation_NN1 Proceedings_NN2 ,_Y 41_MC ,_Y 241-246_MCMC ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  233 <p> -- Griffiths , R.R. , Bigelow , G.E. , Henningfield , J.E .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  233 <p>_Y --_ZZ Griffiths_NP1 ,_Y R.R._NP1 ,_Y Bigelow_NP1_VV0_NN1 ,_Y G.E._NP1 ,_Y Henningfield_NP1 ,_Y J.E_NP1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  234 1980 Similarities in animal and human drug-taking behavior .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  234 1980_MC Similarities_NN2 in_II animal_NN1 and_CC human_JJ_NN1 drug-taking_NN1 behavior_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  235 In N.K. Mello ( Ed .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  235 In_II N.K._NP1 Mello_NP1 (_Y Ed_NP1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  236 ) , Advances in substance abuse : Behavioral and biological research ( pp. 1-90 ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  236 )_Y ,_Y Advances_NN2_VVZ in_II substance_NN1 abuse_NN1 :_Y Behavioral_NP1_JJ_NN1 and_CC biological_JJ research_NN1 (_Y pp._NNU2 1-90_MCMC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  237 Greenwich , CT : JAI Press , Inc .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  237 Greenwich_NP1 ,_Y CT_NP1@_NN1 :_Y JAI_JJ_NP1_NN2 Press_NN1_VV0 ,_Y Inc_JJ ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  238 <p> -- Harris , R.T. , Balster , R.L. 1968 Discriminative control by d.l-amphetamine and saline of lever choice and response patterning .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  238 <p>_Y --_ZZ Harris_NP1 ,_Y R.T._NP1 ,_Y Balster_NP1_NN1 ,_Y R.L._NP1 1968_MC Discriminative_JJ control_NN1 by_II d.l-amphetamine_NN1_JJ and_CC saline_JJ of_IO lever_NN1 choice_NN1 and_CC response_NN1 patterning_VVG_NN1@ ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  239 Psychonomic Science , 10 , 106-107 .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  239 Psychonomic_JJ Science_NN1 ,_Y 10_MC ,_Y 106-107_MCMC ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  240 <p> -- Henningfield , J.E. , Fant , R.V. 1999 Tobacco use as drug addiction : The experimental evidence .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  240 <p>_Y --_ZZ Henningfield_NP1_NN1@ ,_Y J.E._NP1 ,_Y Fant_NP1_NN1 ,_Y R.V._NP1 1999_MC Tobacco_NN1 use_NN1_VV0 as_CSA_II@ drug_NN1 addiction_NN1 :_Y The_AT experimental_JJ evidence_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  241 Nicotine and Tobacco Research , 1 ( Suppl. 1 ) , S31-S35 .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  241 Nicotine_NN1 and_CC Tobacco_NN1 Research_NN1 ,_Y 1_MC1 (_Y Suppl._NP1 1_MC1 )_Y ,_Y S31-S35_NN1_JJ ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  242 <p> -- Higgins , S.T. , Alessi , S.M. , Dantona , R.L. 2002 Voucher-based incentives .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  242 <p>_Y --_ZZ Higgins_NP1 ,_Y S.T._NP1 ,_NP1 Alessi_NP1 ,_Y S.M._NP1 ,_Y Dantona_NP1 ,_Y R.L._NP1 2002_MC Voucher-based_JJ incentives_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  243 A substance abuse treatment -- Higgins , S.T. , Bickel , W.K. , Hughes , J.R .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  243 A_AT1 substance_NN1 abuse_NN1 treatment_NN1 --_ZZ Higgins_NP1 ,_Y S.T._NP1 ,_NP1 Bickel_NP1 ,_Y W.K._NP1 ,_Y Hughes_NP1 ,_Y J.R_NNA ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  244 1994 Influence of an alternative reinforcer on human cocaine self administration .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  244 1994_MC Influence_NN1 of_IO an_AT1 alternative_JJ_NN1 reinforcer_NN1 on_II human_JJ_NN1 cocaine_NN1 self_NN1 administration_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  245 Life Sciences , 55 , 179-187 .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  245 Life_NN1 Sciences_NN2 ,_Y 55_MC ,_Y 179-187_MCMC ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  246 <p> -- Higgins , S.T. , Budney , A.J. , Bickel , W.K. , Hughes , J.R. , Foerg , F. , Badger , G. 1993 Achieving cocaine abstinence with a behavioral approach .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  246 <p>_Y --_ZZ Higgins_NP1 ,_Y S.T._NP1 ,_NP1 Budney_NP1 ,_Y A.J._NP1 ,_Y Bickel_NP1 ,_Y W.K._NP1 ,_Y Hughes_NP1 ,_Y J.R._NNA ,_Y Foerg_NP1_VV0_NN1 ,_Y F._NP1_RA@ ,_Y Badger_NN1_VV0@ ,_Y G._NP1 1993_MC Achieving_VVG cocaine_NN1 abstinence_NN1 with_IW a_AT1 behavioral_JJ_NN1 approach_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  247 American Journal of Psychiatry , 150 , 763-769 .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  247 American_JJ Journal_NN1 of_IO Psychiatry_NP1_NN1 ,_Y 150_MC ,_Y 763-769_MCMC ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  248 <p> -- Johanson , C.E. , Balster , R.L. 1978 A summary of results of drug self-administration studies using substitution procedures in rhesus monkeys .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  248 <p>_Y --_ZZ Johanson_NP1_NN1@ ,_Y C.E._NP1 ,_Y Balster_NP1_NN1 ,_Y R.L._NP1 1978_MC A_ZZ1_AT1@ summary_NN1 of_IO results_NN2 of_IO drug_NN1 self-administration_NN1_JJ studies_NN2 using_VVG substitution_NN1 procedures_NN2 in_II rhesus_NN1 monkeys_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  249 Bulletin on Narcotics , 30 , 43-54 .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  249 Bulletin_NN1 on_II Narcotics_NN2 ,_Y 30_MC ,_Y 43-54_MCMC ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  250 <p> -- Kenny , P.J. 2007 Brain reward systems and compulsive drug use .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  250 <p>_Y --_ZZ Kenny_NP1 ,_Y P.J._NP1 2007_MC Brain_NN1 reward_NN1 systems_NN2 and_CC compulsive_JJ drug_NN1 use_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  251 Trends in Pharmacological Science , 28 , 135-14 I. <p> -- Koob , G.F. 1992 Neural mechanisms of drug reinforcement .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  251 Trends_NN2 in_II Pharmacological_JJ_NP1 Science_NN1 ,_Y 28_MC ,_Y 135-14_MCMC I._NP1 <p>_Y --_ZZ Koob_NP1_NN1@ ,_Y G.F._NP1 1992_MC Neural_JJ mechanisms_NN2 of_IO drug_NN1 reinforcement_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  252 Annals of the New York Academy of Sciences , 28 , 171 - 19 I. <p> -- Koob , G.R. , Le Moal , M. 2006 Neurobiology of Addiction .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  252 Annals_NN2 of_IO the_AT New_NP1 York_NP1 Academy_NN1 of_IO Sciences_NN2 ,_Y 28_MC ,_Y 171_MC -_- 19_MC I._NP1 <p>_Y --_ZZ Koob_NP1_NN1@ ,_Y G.R._NP1 ,_Y Le_NP1 Moal_NP1 ,_Y M._NN1 2006_MC Neurobiology_NN1 of_IO Addiction_NPX ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  253 London : Academic Press .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  253 London_NP1 :_Y Academic_JJ Press_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  254 <p> -- Kreek , M.J. , Nielsen , D.A. : Alcoholism , opiate and cocaine addiction .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  254 <p>_Y --_ZZ Kreek_NP1_NN1@ ,_Y M.J._NP1 ,_Y Nielsen_NP1 ,_Y D.A._NP1 :_Y Alcoholism_NN1 ,_Y opiate_NN1_VV0 and_CC cocaine_NN1 addiction_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  255 Neuromolecular Medicine , 5 , 85-108 .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  255 Neuromolecular_JJ Medicine_NN1 ,_Y 5_MC ,_Y 85-108_MCMC ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  256 <p> -- Madras , B.K. , Colvis , C.M. , Pollock , J.D. , Rutter , J.L. , Shurtleff , D. , von Zastrow , : M. ( Eds. ) 2006 Cell biology of addiction .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  256 <p>_Y --_ZZ Madras_NP1_NN1@ ,_Y B.K._NP1 ,_Y Colvis_NP1 ,_Y C.M._NNU ,_Y Pollock_NP1 ,_Y J.D._NP1 ,_Y Rutter_NP1 ,_Y J.L._NP1 ,_Y Shurtleff_NP1_VV0_NN1 ,_Y D._NP1 ,_Y von_NP1 Zastrow_NP1 ,_Y :_Y M._NNU@_NN1 (_Y Eds._NN2 )_Y 2006_MC Cell_NN1 biology_NN1 of_IO addiction_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  257 Cold Spring Harbor , NY : Cold Spring Harbor Laboratory Press .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  257 Cold_JJ_NN1 Spring_NN1 Harbor_NN1 ,_Y NY_NP1 :_Y Cold_JJ Spring_NN1 Harbor_NN1 Laboratory_NN1 Press_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  258 <p> -- Martin , W.R. , Sloan , B.S. , Sapira , J.D. , Jasinski , D.R. 1971 Physiologic , subjective , and behavioral effects of amphetamine , methamphetamine , ephedrine , phenmetrazine , and methylphenidaie in man .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  258 <p>_Y --_ZZ Martin_NP1 ,_Y W.R._NP1 ,_Y Sloan_NP1_NN1 ,_Y B.S._NP1 ,_Y Sapira_NP1 ,_Y J.D._NP1 ,_Y Jasinski_NP1_NN1 ,_Y D.R._NNB 1971_MC Physiologic_JJ ,_Y subjective_JJ ,_Y and_CC behavioral_JJ_NN1 effects_NN2 of_IO amphetamine_NN1 ,_Y methamphetamine_VV0_NN1 ,_Y ephedrine_NN1_JJ ,_Y phenmetrazine_NN1 ,_Y and_CC methylphenidaie_NN1 in_II man_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  259 Clinical Pharmacology and Therapeutics , 12 , 245-258 .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  259 Clinical_JJ Pharmacology_NN1 and_CC Therapeutics_NN1 ,_Y 12_MC ,_Y 245-258_MCMC ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  260 <p> -- McKim , W. 2006 Drugs and behavior : An introduction to behavioral pharmacology , ( 6th ed .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  260 <p>_Y --_ZZ McKim_NP1 ,_Y W._NP1 2006_MC Drugs_NN2 and_CC behavior_NN1 :_Y An_AT1 introduction_NN1 to_II behavioral_JJ_NN1 pharmacology_NN1 ,_Y (_Y 6th_MD ed_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  261 ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  261 )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  262 Upper Saddle River , N J : Pearson .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  262 Upper_JJ Saddle_NP1 River_NNL1 ,_Y N_ZZ1 J_ZZ1 :_Y Pearson_NP1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  263 <p> -- Mello , N.K. , Mendelson , J.H. 1965 Operant analysis of drinking patterns of chronic alcoholics .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  263 <p>_Y --_ZZ Mello_NP1_NN1@ ,_Y N.K._NP1 ,_Y Mendelson_NP1 ,_Y J.H._NP1 1965_MC Operant_JJ analysis_NN1 of_IO drinking_VVG_NN1 patterns_NN2 of_IO chronic_JJ alcoholics_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  264 Nature , , 206 , 43 -46 .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  264 Nature_NN1 ,_Y ,_Y 206_MC ,_Y 43_MC -46_MC ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  265 <p> -- Mello , N.K. , Mendelson , J.H. 1978 Heroin self-administration : An operant analysis .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  265 <p>_Y --_ZZ Mello_NP1_NN1@ ,_Y N.K._NP1 ,_Y Mendelson_NP1 ,_Y J.H._NP1 1978_MC Heroin_NN1 self-administration_NN1 :_Y An_AT1 operant_JJ_NN1 analysis_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  266 NIDA , R.E. , McNamee , H.B. , Mirin , S.M. , Altman , J.L. 1976 Analysis and modification of opiate reinforcement .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  266 NIDA_NP1_NN1 ,_Y R.E._NP1 ,_Y McNamee_NP1 ,_Y H.B._NP1 ,_Y Mirin_NP1_NN1 ,_Y S.M._NP1 ,_Y Altman_NP1 ,_Y J.L._NP1 1976_MC Analysis_NN1 and_CC modification_NN1 of_IO opiate_NN1 reinforcement_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  267 The International Journal of the Addictions , 11 , 467-484 .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  267 The_AT International_JJ Journal_NN1 of_IO the_AT Addictions_NPX ,_Y 11_MC ,_Y 467-484_MCMC ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  268 <p> -- Morse , W.H. , Kelleher , R.T .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  268 <p>_Y --_ZZ Morse_NP1_NN1@ ,_Y W.H._NP1 ,_Y Kelleher_NP1 ,_Y R.T_NP1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  269 1970 Schedules as fundamental determinants of behavior .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  269 1970_MC Schedules_NN2 as_CSA_RG@ fundamental_JJ determinants_NN2 of_IO behavior_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  270 In W.N. Schoenfeld ( Ed .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  270 In_II W.N._NP1 Schoenfeld_NP1 (_Y Ed_NP1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  271 ) , The Theory of Reinforcement Schedules ( pp. 43-61 ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  271 )_Y ,_Y The_AT Theory_NN1 of_IO Reinforcement_NN1 Schedules_NN2 (_Y pp._NNU2 43-61_MCMC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  272 New York : Appleton-Century-Crofts .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  272 New_NP1 York_NP1 :_Y Appleton-Century-Crofts_NP1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  273 <p> -- Nelson , A. , Killcross , S. 2006 Amphetamine exposure enhances habit formation .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  273 <p>_Y --_ZZ Nelson_NP1 ,_Y A._ZZ ,_Y Killcross_NP1_VV0_NN1 ,_Y S._NP1 2006_MC Amphetamine_NP1 exposure_NN1 enhances_VVZ habit_NN1 formation_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  274 Journal of Neuroscience , 26 , 3805-3812 .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  274 Journal_NN1 of_IO Neuroscience_NP1 ,_Y 26_MC ,_Y 3805-3812_MCMC ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  275 <p> -- Petry , N.M. , Martin , B. 2002 Low-cost contingency management for treating cocaine- and opioid abusing methadone patients .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  275 <p>_Y --_ZZ Petry_NN1_NP1 ,_Y N.M._NP1 ,_Y Martin_NP1 ,_Y B._NP1 2002_MC Low-cost_JJ contingency_NN1 management_NN1 for_IF treating_VVG cocaine-_JJ_NN1 and_CC opioid_JJ_NN1 abusing_JJ@_NN1@_VVG methadone_NN1 patients_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  276 Journal of Consulting and Clinical Psychology , 70 , 398-405 .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  276 Journal_NN1 of_IO Consulting_NN1_JJ_VVG and_CC Clinical_JJ Psychology_NN1 ,_Y 70_MC ,_Y 398-405_MCMC ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  277 <p> -- Pickens , R.W. 1977 Behavioral pharmacology : A brief history .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  277 <p>_Y --_ZZ Pickens_NN2_NP1 ,_Y R.W._NP1 1977_MC Behavioral_JJ pharmacology_NN1 :_Y A_ZZ1_AT1@ brief_JJ history_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  278 In T. Thompson P.B. Dews ( Eds .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  278 In_II T._NP1 Thompson_NP1 P.B._FO Dews_NN2 (_Y Eds_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  279 ) , Advances in behavioral pharmacology ( pp. 229-257 ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  279 )_Y ,_Y Advances_NN2_VVZ in_II behavioral_JJ_NN1 pharmacology_NN1 (_Y pp._NNU2 229-257_MCMC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  280 New York : Academic Press .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  280 New_NP1 York_NP1 :_Y Academic_JJ Press_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  281 <p> -- Pickens , R.W. , Thompson , T. ( Eds. ) 1970 Stimulus properties of , K.L. , Bigelow , G.E .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  281 <p>_Y --_ZZ Pickens_NN2_NP1 ,_Y R.W._NP1 ,_Y Thompson_NP1 ,_Y T._NP1 (_Y Eds._NN2 )_Y 1970_MC Stimulus_NPX properties_NN2 of_IO ,_Y K.L._NP1 ,_Y Bigelow_NP1_VV0_NN1 ,_Y G.E_NP1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  282 1991 Subjective and discriminative effects of drugs .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  282 1991_MC Subjective_JJ and_CC discriminative_JJ effects_NN2 of_IO drugs_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  283 Behavioural Pharmacology , 2 , 293-313 .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  283 Behavioural_JJ Pharmacology_NN1_NP1 ,_Y 2_MC ,_Y 293-313_MCMC ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  284 <p> -- Preston , K.L. , Bigelow , G.E. , Bickel , W. , Liebson , I.A. 1987 Three-choice drug discrimination in opioid-dependent humans : Hydromorphone , naloxone and saline .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  284 <p>_Y --_ZZ Preston_NP1 ,_Y K.L._NP1 ,_Y Bigelow_NP1_VV0_NN1 ,_Y G.E._NP1 ,_Y Bickel_NP1 ,_Y W._NP1 ,_Y Liebson_NP1 ,_Y I.A._NP1 1987_MC Three-choice_JJ@_NN1 drug_NN1 discrimination_NN1 in_II opioid-dependent_JJ humans_NN2 :_Y Hydromorphone_NP1_VV0_NN1 ,_Y naloxone_NN1_VV0 and_CC saline_JJ ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  285 Journal of Pharmacology and Experimental Therapeutics , 243 , 1002-1009 .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  285 Journal_NN1 of_IO Pharmacology_NP1_NN1 and_CC Experimental_JJ Therapeutics_NN1 ,_Y 243_MC ,_Y 1002-1009_MCMC ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  286 <p> -- Robinson , T.E. , Berridge , K.C. 1993 The neural basis of drug craving : An incentive-sensitization theory of addiction .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  286 <p>_Y --_ZZ Robinson_NP1 ,_Y T.E._NP1 ,_Y Berridge_NP1 ,_Y K.C._NP1 1993_MC The_AT neural_JJ_NN1 basis_NN1 of_IO drug_NN1 craving_VVG_NN1@ :_Y An_AT1 incentive-sensitization_JJ_NN1 theory_NN1 of_IO addiction_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  287 Brain Research Reviews , 18 , 247-291 .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  287 Brain_NN1 Research_NN1 Reviews_NN2_VVZ ,_Y 18_MC ,_Y 247-291_MCMC ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  288 Schuster , C.R. , Balster , R.L. 1977 The discriminative stimulus properties of drugs .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  288 Schuster_NN1_NP1@ ,_Y C.R._NP1 ,_Y Balster_NP1_NN1 ,_Y R.L._NP1 1977_MC The_AT discriminative_JJ stimulus_NN1 properties_NN2 of_IO drugs_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  289 In T. Thompson P.B. Dews , ( Eds .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  289 In_II T._NP1 Thompson_NP1 P.B._FO Dews_NN2 ,_Y (_Y Eds_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  290 ) , Advances in behavioral pharmacology , Vol. 1 ( pp. 85-138 ) , New York : Academic Press .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  290 )_Y ,_Y Advances_NN2_VVZ in_II behavioral_JJ_NN1 pharmacology_NN1 ,_Y Vol._NN1 1_MC1 (_Y pp._NNU2 85-138_MCMC )_Y ,_Y New_NP1 York_NP1 :_Y Academic_JJ Press_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  291 <p> -- Schuster , C.R. , Dockens , W.S. , Woods , J.H. 1966 Behavioral variables affecting the development of amphetamine tolerance .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  291 <p>_Y --_ZZ Schuster_NN1_NP1 ,_Y C.R._NP1 ,_Y Dockens_NP1_NN2 ,_Y W.S._NP2 ,_Y Woods_NP1 ,_Y J.H._NP1 1966_MC Behavioral_JJ variables_NN2 affecting_VVG the_AT development_NN1 of_IO amphetamine_NN1 tolerance_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  292 Psychopharmacologia , 9 , 179-182 .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  292 Psychopharmacologia_NN1_NP1@ ,_Y 9_MC ,_Y 179-182_MCMC ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  293 <p> -- Shaham , Y. , Shalev , U. , Lu , L. , De Wit , of drug relapse : History , methodology and major findings .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  293 <p>_Y --_ZZ Shaham_NP1_NN1@ ,_Y Y._NP1 ,_Y Shalev_NP1 ,_Y U._NP1 ,_Y Lu_NP1_NN1 ,_Y L._NP1 ,_Y De_NP1 Wit_NN1 ,_Y of_IO drug_NN1 relapse_NN1_VV0 :_Y History_NN1 ,_Y methodology_NN1 and_CC major_JJ findings_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  294 Psychopharmacology , 168 , 3-20 .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  294 Psychopharmacology_NN1_NP1@ ,_Y 168_MC ,_Y 3-20_MCMC ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  295 <p> -- Sidman , M. 1960 Tactics of scientific research .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  295 <p>_Y --_ZZ Sidman_NN1_NP1 ,_Y M._NN1 1960_MC Tactics_NN2 of_IO scientific_JJ research_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  296 New York : Basic Books .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  296 New_NP1 York_NP1 :_Y Basic_JJ Books_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  297 Silverman , K. , Svikis , D. , Wong , C.J. , Hampton , J. , Stitzer , M.L. , Bigelow , G.E .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  297 Silverman_NN1_NP1@ ,_Y K._NP1 ,_Y Svikis_NP1_NN1 ,_Y D._NP1 ,_Y Wong_NP1_VV0_NN1 ,_Y C.J._NP1 ,_Y Hampton_NP1 ,_Y J._NP1 ,_Y Stitzer_NP1 ,_Y M.L._NNU ,_Y Bigelow_NP1_VV0_NN1 ,_Y G.E_NP1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  298 2002 A reinforcement-based therapeutic workplace for the treatment of drug abuse : Three-year abstinence outcomes .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  298 2002_MC A_ZZ1_AT1@ reinforcement-based_JJ therapeutic_JJ workplace_NN1 for_IF the_AT treatment_NN1 of_IO drug_NN1 abuse_NN1 :_Y Three-year_JJ abstinence_NN1 outcomes_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  299 Experimental and Clinical Psychopharmacology , 10 , 228-240 .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  299 Experimental_JJ and_CC Clinical_JJ Psychopharmacology_NN1_NP1 ,_Y 10_MC ,_Y 228-240_MCMC ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  300 <p> -- Skinner , B.F. 1938 The behavior of organisms .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  300 <p>_Y --_ZZ Skinner_NP1_NN1@ ,_Y B.F._NP1 1938_MC The_AT behavior_NN1 of_IO organisms_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  301 New York : Appleton-Century-Crofts .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  301 New_NP1 York_NP1 :_Y Appleton-Century-Crofts_NP1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  302 <p> -- Stitzer , M.L. , Bigelow , G.E. , Liebson , I. 1979 Reducing benzodiazepine self-administration with contingent reinforcement .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  302 <p>_Y --_ZZ Stitzer_NP1_NN1@ ,_Y M.L._NNU ,_Y Bigelow_NP1_VV0_NN1 ,_Y G.E._NP1 ,_Y Liebson_NP1 ,_Y I._NP1 1979_MC Reducing_JJ@_VVG benzodiazepine_NN1 self-administration_NN1 with_IW contingent_JJ reinforcement_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  303 Addictive Behaviors. 4 , 245-252 .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  303 Addictive_JJ Behaviors._NP1 4_MC ,_Y 245-252_MCMC ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  304 <p> -- Stitzer , M.L. , Bigelow , G.E. , Liebson , I. 1984 Contingent methadone take-home privileges : Effects on compliance with fee payment schedules .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  304 <p>_Y --_ZZ Stitzer_NP1_NN1@ ,_Y M.L._NNU ,_Y Bigelow_NP1_VV0_NN1 ,_Y G.E._NP1 ,_Y Liebson_NP1 ,_Y I._NP1 1984_MC Contingent_JJ methadone_NN1 take-home_JJ privileges_NN2 :_Y Effects_NN2 on_II compliance_NN1 with_IW fee_NN1 payment_NN1 schedules_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  305 Drug Alcohol Dependence , 13 , 395-399 , <p> -- Stitzer , M.L. , Bigelow , G.E. , Liebson , I. 1985 Behavior therapy in drug abuse treatment : Review and evaluation .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  305 Drug_NN1 Alcohol_NN1 Dependence_NN1 ,_Y 13_MC ,_Y 395-399_MCMC ,_Y <p>_Y --_ZZ Stitzer_NP1_NN1@ ,_Y M.L._NNU ,_Y Bigelow_NP1_VV0_NN1 ,_Y G.E._NP1 ,_Y Liebson_NP1 ,_Y I._NP1 1985_MC Behavior_NP1_NN1 therapy_NN1 in_II drug_NN1 abuse_NN1 treatment_NN1 :_Y Review_NN1_NP1@_VV0@ and_CC evaluation_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  306 Stitzer , M.L. , Vandrey , R. 2008 Contingency management : Utility in the treatment of drug abuse disorders .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  306 Stitzer_NP1_NN1@ ,_Y M.L._NNU ,_Y Vandrey_NP1 ,_Y R._NP1 2008_MC Contingency_NN1 management_NN1 :_Y Utility_NN1 in_II the_AT treatment_NN1 of_IO drug_NN1 abuse_NN1 disorders_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  307 Clinical Pharmacology and Experimental Therapeutics , 83 , 644-647 .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  307 Clinical_JJ Pharmacology_NN1 and_CC Experimental_JJ Therapeutics_NN1 ,_Y 83_MC ,_Y 644-647_MCMC ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  308 <p> -- Stoller , K. , Bigelow , G.E. , Walsh , S.L. , Strain , E.C .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  308 <p>_Y --_ZZ Stoller_NN1_NP1 ,_Y K._NP1 ,_Y Bigelow_NP1_VV0_NN1 ,_Y G.E._NP1 ,_Y Walsh_NP1 ,_Y S.L._NP1 ,_Y Strain_VV0_NN1_NP1@ ,_Y E.C_NP1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  309 2001 Effects of buprenorphine/naloxone in opioid-dependent humans .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  309 2001_MC Effects_NN2 of_IO buprenorphine/naloxone_NN1 in_II opioid-dependent_JJ humans_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  310 Psychopharmacology , 154 , 230-242 .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  310 Psychopharmacology_NN1_NP1@ ,_Y 154_MC ,_Y 230-242_MCMC ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  311 <p> -- Thompson , T. , Schuster , C.R. 1968 Behavioral Pharmacology .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  311 <p>_Y --_ZZ Thompson_NP1 ,_Y T._NP1 ,_Y Schuster_NP1_NN1 ,_Y C.R._NP1 1968_MC Behavioral_JJ_NP1 Pharmacology_NN1_NP1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  312 Englewood Cliffs , N.J. : Prentice-Hall .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  312 Englewood_NN1_NP1@ Cliffs_NN2 ,_Y N.J._NP1 :_Y Prentice-Hall_NP1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  313 <p> -- Thompson , T. , Schuster , C.R. 1964 Morphine self-administration , food-reinforced , and avoidance behaviors in Rhesus monkeys .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  313 <p>_Y --_ZZ Thompson_NP1 ,_Y T._NP1 ,_Y Schuster_NP1_NN1 ,_Y C.R._NP1 1964_MC Morphine_NN1 self-administration_NN1 ,_Y food-reinforced_NN1_JJ ,_Y and_CC avoidance_NN1 behaviors_NN2 in_II Rhesus_NN1 monkeys_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  314 Psychopharmacologia , 5 , 87-94 .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  314 Psychopharmacologia_NN1_NP1@ ,_Y 5_MC ,_Y 87-94_MCMC ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  315 <p> -- Uhl , G.R. 2004 Molecular genetics of substance abuse vulnerability : Remarkable recent convergence of genome scan results .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  315 <p>_Y --_ZZ Uhl_NP1 ,_Y G.R._NP1 2004_MC Molecular_JJ genetics_NN1 of_IO substance_NN1 abuse_NN1 vulnerability_NN1 :_Y Remarkable_JJ recent_JJ convergence_NN1 of_IO genome_NN1 scan_NN1_VV0 results_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  316 Annals of New York Academy of Sciences , 1025 , 1-13 .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  316 Annals_NN2 of_IO New_NP1 York_NP1 Academy_NN1 of_IO Sciences_NN2 ,_Y 1025_MC ,_Y 1-13_MCMC ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  317 <p> -- U.S. Department of Health , Education and Welfare ( USDHEW ) .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  317 <p>_Y --_ZZ U.S._NP1 Department_NN1 of_IO Health_NN1 ,_Y Education_NN1 and_CC Welfare_NN1 (_Y USDHEW_NP1 )_Y ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  318 1988 The health consequences of smoking : Nicotine addiction .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  318 1988_MC The_AT health_NN1 consequences_NN2 of_IO smoking_NN1_VVG_JJ :_Y Nicotine_NN1 addiction_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  319 A report of the Surgeon General .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  319 A_AT1 report_NN1 of_IO the_AT Surgeon_NN1 General_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  320 U.S. Department of Health and Human Services , Public Health Service , Centers , Office on Smoking and Health .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  320 U.S._NP1 Department_NN1 of_IO Health_NN1 and_CC Human_JJ_NN1 Services_NN2 ,_Y Public_JJ_NN1 Health_NN1 Service_NN1 ,_Y Centers_NN2 ,_Y Office_NN1 on_II Smoking_NN1_VVG_JJ and_CC Health_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  321 DHHS Publication No .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  321 DHHS_NP1 Publication_NN1 No_XX ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  322 ( CDC ) 88-8406 .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  322 (_Y CDC_NP1 )_Y 88-8406_MCMC ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  323 <p> -- Vocci , F. Ling , W. 2005 Medications development : successes and challenges .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  323 <p>_Y --_ZZ Vocci_NN1_NP1_NN2@ ,_Y F._NP1 Ling_NN1 ,_Y W._NP1 2005_MC Medications_NN2 development_NN1 :_Y successes_NN2 and_CC challenges_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  324 Pharmacology and Therapeutics , 108 , 94-108 .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  324 Pharmacology_NN1_NP1@ and_CC Therapeutics_NN1 ,_Y 108_MC ,_Y 94-108_MCMC ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  325 <p> -- Walsh , S.L. , Eissenberg , T. 2003 The clinical pharmacology of buprenorphine : Extrapolating from the laboratory to the clinic .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  325 <p>_Y --_ZZ Walsh_NP1 ,_Y S.L._NP1 ,_Y Eissenberg_NP1 ,_Y T._NP1 2003_MC The_AT clinical_JJ pharmacology_NN1 of_IO buprenorphine_NN1 :_Y Extrapolating_VVG_NP1 from_II the_AT laboratory_NN1 to_II the_AT clinic_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  326 Drug Alcohol Dependence , 70(Suppl) , S13-$27 .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  326 Drug_NN1 Alcohol_NN1 Dependence_NN1 ,_Y 70(Suppl)_FO ,_Y S13-$27_FO ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  327 <p> -- Weeks , J.R .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  327 <p>_Y --_ZZ Weeks_NP1 ,_Y J.R_NNA ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  328 1962 Experimental morphine addiction : Method for automatic intravenous injection in unrestrained rats .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  328 1962_MC Experimental_JJ morphine_NN1 addiction_NN1 :_Y Method_NN1 for_IF automatic_JJ intravenous_JJ injection_NN1 in_II unrestrained_JJ rats_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  329 Science , 138 , 143-144 .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  329 Science_NN1 ,_Y 138_MC ,_Y 143-144_MCMC ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  330 <p> -- Wikler , A. 1973 Dynamics of drug dependence .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  330 <p>_Y --_ZZ Wikler_NN1_NP1 ,_Y A._ZZ 1973_MC Dynamics_NN of_IO drug_NN1 dependence_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  331 Implications of a conditioning theory for research and treatment .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  331 Implications_NN2 of_IO a_AT1 conditioning_NN1 theory_NN1 for_IF research_NN1 and_CC treatment_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  332 Archives of General Psychiatry , 28 , 611-6l6 .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  332 Archives_NN2 of_IO General_JJ_NN1 Psychiatry_NN1_NP1 ,_Y 28_MC ,_Y 611-6l6_NN1_JJ ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  333 <p> By Robert L. Balster ; Sharon L. Walsh and George E. Bigelow <p> Robert L. Balster , Ph.D. , is Director of the Institute for Drug and Alcohol Studies , Butler Professor of Pharmacology and Toxicology , and Research Professor of Psychology and Psychiatry at Virginia Commonwealth University .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  333 <p>_Y By_II Robert_NP1 L._NP1 Balster_NP1_NN1 ;_Y Sharon_NP1 L._NP1 Walsh_NP1 and_CC George_NP1 E._NP1 Bigelow_NP1_NN1 <p>_Y Robert_NP1 L._NP1 Balster_NP1 ,_Y Ph.D._NNA ,_Y is_VBZ Director_NN1 of_IO the_AT Institute_NN1 for_IF Drug_NN1 and_CC Alcohol_NN1 Studies_NN2 ,_Y Butler_NP1 Professor_NN1 of_IO Pharmacology_NP1_NN1 and_CC Toxicology_NP1_NN1 ,_Y and_CC Research_NN1_VV0@ Professor_NN1 of_IO Psychology_NN1 and_CC Psychiatry_NN1_NP1 at_II Virginia_NP1 Commonwealth_NN1 University_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  334 He has published over 250 scientific articles in animal behavioral Alcohol Dependence .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  334 He_PPHS1 has_VHZ published_VVN over_RG 250_MC scientific_JJ articles_NN2 in_II animal_NN1 behavioral_NN1_JJ Alcohol_NN1 Dependence_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  335 <p> Sharon L. Walsh , Ph.D. , is Director of the Center on Drug and Alcohol Research , Professor of Behavioral Sciences and Adjunct Professor of Psychiatry at the University of Kentucky .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  335 <p>_Y Sharon_NP1 L._NP1 Walsh_NP1 ,_Y Ph.D._NNA ,_Y is_VBZ Director_NN1 of_IO the_AT Center_NN1 on_II Drug_NN1 and_CC Alcohol_NN1 Research_NN1 ,_Y Professor_NN1 of_IO Behavioral_JJ_NN1_NP1 Sciences_NN2 and_CC Adjunct_NN1 Professor_NN1 of_IO Psychiatry_NN1_NP1 at_II the_AT University_NN1 of_IO Kentucky_NP1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  336 She has published over 70 scientific papers on the behavioral pharmacology of substance abuse treatment in humans .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  336 She_PPHS1 has_VHZ published_VVN over_RG 70_MC scientific_JJ papers_NN2 on_II the_AT behavioral_JJ_NN1 pharmacology_NN1 of_IO substance_NN1 abuse_NN1 treatment_NN1 in_II humans_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  337 <p> George E. Bigelow , Ph.D. , is Director of the Behavioral Pharmacology Research Unit and Professor in the Department of Psychiatry and Behavioral Sciences at Johns Hopkins University School of Medicine .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  337 <p>_Y George_NP1 E._NP1 Bigelow_NP1 ,_Y Ph.D._NNA ,_Y is_VBZ Director_NN1 of_IO the_AT Behavioral_JJ_NP1_NN1 Pharmacology_NN1_NP1 Research_NN1 Unit_NN1 and_CC Professor_NN1 in_II the_AT Department_NN1 of_IO Psychiatry_NP1_NN1 and_CC Behavioral_JJ_NN1 Sciences_NN2 at_II Johns_NP1 Hopkins_NP1 University_NN1 School_NN1 of_IO Medicine_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  338 He has published over 200 scientific articles on the human behavioral pharmacology of substance abuse and on substance abuse treatment .
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  338 He_PPHS1 has_VHZ published_VVN over_RG 200_MC scientific_JJ articles_NN2 on_II the_AT human_JJ_NN1 behavioral_JJ_NN1 pharmacology_NN1 of_IO substance_NN1 abuse_NN1 and_CC on_II substance_NN1 abuse_NN1 treatment_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  A    0  339 <p>
SENTPOS COCA_acad_wlp_2009_01_FILE##4070858 COCA  B    0  339 <p>_Y
